[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 635
1. Obulareddy SJ, Xin J, Truskinovsky AM, Anderson JK, Franklin MJ, Dudek AZ: Metanephric adenoma of the kidney: an unusual diagnostic challenge. Rare Tumors; 2010;2(2):e38
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma of the kidney: an unusual diagnostic challenge.
  • Although metanephric adenoma (MA) is a rare, benign neoplasm of epithelial cells, it is often difficult to distinguish this entity from other malignant neoplasms preoperatively.
  • We report a case of a large renal mass for which preoperative diagnosis was indeterminate, with the differential diagnosis including Wilm's tumor, MA, and papillary renal cell carcinoma (PRCC).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21139840.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2994510
  • [Keywords] NOTNLM ; Wilm’s tumor / differential diagnosis. / metanephric adenoma / papillary renal cell carcinoma
  •  go-up   go-down


2. Bastide C, Rambeaud JJ, Bach AM, Russo P: Metanephric adenoma of the kidney: clinical and radiological study of nine cases. BJU Int; 2009 Jun;103(11):1544-8
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma of the kidney: clinical and radiological study of nine cases.
  • OBJECTIVE To analyse the clinical and radiological features of metanephric adenoma (MA, a rare benign renal tumour) in nine patients, and to review previous reports.
  • Renal colour Doppler ultrasonography (US), abdominal computed tomography and abdominal magnetic resonance imaging were used in seven, eight and four patients, respectively.
  • CONCLUSIONS Renal MA is a benign tumour occurring mainly in young and middle-aged women.
  • Based on a combination of clinical and imaging features, it might be possible to suspect the diagnosis of MA and propose a preoperative diagnostic biopsy, a partial nephrectomy or active surveillance.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology. Nephrectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19220269.001).
  • [ISSN] 1464-410X
  • [Journal-full-title] BJU international
  • [ISO-abbreviation] BJU Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


3. Matsuda K, Kousaka Y, Nagamine N, Tsunoda N, Taniyama H: Papillary renal adenoma of distal nephron differentiation in a horse. J Vet Med Sci; 2007 Jul;69(7):763-5
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary renal adenoma of distal nephron differentiation in a horse.
  • A 20-year-old thoroughbred mare had a mass in the right kidney.
  • From these results, this case was diagnosed as papillary renal adenoma of distal nephron differentiation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17675811.001).
  • [ISSN] 0916-7250
  • [Journal-full-title] The Journal of veterinary medical science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


Advertisement
4. Nakane K, Yuhara K, Kanimoto Y: [Renal adenoma treated with partial nephrectomy: a case report]. Hinyokika Kiyo; 2007 Jul;53(7):473-5
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Renal adenoma treated with partial nephrectomy: a case report].
  • We report a case of renal adenoma which was diagnosed as renal cell carcinoma preoperatively.
  • A 78-year-old man, who had been under observation for bladder cancer for 4 years, was incidentally found to have a small right renal tumor at follow-up computed tomography (CT).
  • Enhanced CT demonstrated a tumor which was hypervascular, 10 x 10 mm size, at the lower pole of the right kidney.
  • The preoperative diagnosis was renal cell carcinoma, cT1aN0M0, and we performed right partial nephrectomy.
  • The histopathorogical finding was renal adenoma.
  • Renal adenomas are benign tumors and not uncommon in autopsy cases.
  • However, when they are detected clinically, it is difficult to distinguish them from renal cell carcinoma preoperatively.
  • [MeSH-major] Adenoma / surgery. Kidney Neoplasms / surgery. Nephrectomy
  • [MeSH-minor] Aged. Carcinoma, Renal Cell. Diagnosis, Differential. Humans. Male. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17702180.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


5. Bhat S, Chandran V: Villous adenoma of the renal pelvis and ureter. Indian J Urol; 2010 Oct;26(4):598-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Villous adenoma of the renal pelvis and ureter.
  • Villous adenoma originating in the urinary tract is a rare condition.
  • Mucus-filled kidney (muconephrosis), one of the manifestations of this condition, occurs due to intestinal type of metaplastic changes occurring in the urothelium.
  • We are reporting the third case of muconephrosis due to villous adenomatous changes of the renal pelvis and ureter.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1999 Jul;23(7):764-71 [10403298.001]
  • [Cites] Urology. 2002 Aug;60(2):344 [12137843.001]
  • [Cites] J Chin Med Assoc. 2007 Jan;70(1):33-5 [17276931.001]
  • (PMID = 21369402.001).
  • [ISSN] 1998-3824
  • [Journal-full-title] Indian journal of urology : IJU : journal of the Urological Society of India
  • [ISO-abbreviation] Indian J Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3034078
  • [Keywords] NOTNLM ; Muconephrosis / villous adenoma
  •  go-up   go-down


6. Rhodes MC, Bucher JR, Peckham JC, Kissling GE, Hejtmancik MR, Chhabra RS: Carcinogenesis studies of benzophenone in rats and mice. Food Chem Toxicol; 2007 May;45(5):843-51
Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was a positive trend in the incidence of renal tubule adenoma in male rats; these neoplasms were accompanied by significantly increased incidences of renal tubule hyperplasia.
  • Increased incidences of mononuclear cell leukemia were observed in male rats exposed to 312 or 625 ppm benzophenone and in female rats exposed to 625 ppm benzophenone.
  • In male mice, there were significantly increased incidences of hepatocellular adenoma in the 625 and 1250 ppm groups.
  • In female mice, the incidences of hepatocellular adenoma in the 625 and 1250 ppm groups were higher than expected after adjusting for the lower body weights in these groups.
  • The incidences of kidney nephropathy in exposed groups of female mice, as well as the severity of nephropathy in exposed groups of males, were significantly increased.
  • Under the conditions of these 2-year studies, there was some evidence of carcinogenic activity of benzophenone in male F344/N rats based on increased incidences of renal tubule adenoma.
  • There was equivocal evidence of carcinogenic activity of benzophenone in female F344/N rats based on the marginal increased incidences of mononuclear cell leukemia and histiocytic sarcoma.
  • There was some evidence of carcinogenic activity of benzophenone in male B6C3F(1) mice based on increased incidences of hepatocellular neoplasms, primarily adenoma.
  • There was some evidence of carcinogenic activity of benzophenone in female B6C3F(1) mice based on increased incidences of histiocytic sarcoma; the incidences of hepatocellular adenoma in female B6C3F(1) mice may have been related to benzophenone exposure.
  • [MeSH-minor] Adenoma / chemically induced. Adenoma / pathology. Animals. Dose-Response Relationship, Drug. Female. Histiocytic Disorders, Malignant / chemically induced. Histiocytic Disorders, Malignant / pathology. Kidney Neoplasms / chemically induced. Kidney Neoplasms / pathology. Leukemia / chemically induced. Leukemia / pathology. Liver Neoplasms / chemically induced. Liver Neoplasms / pathology. Male. Mice. Mice, Inbred Strains. Rats. Rats, Inbred F344. Sarcoma / chemically induced. Sarcoma / pathology. Sex Factors

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. BENZOPHENONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Acad Dermatol. 2003 Nov;49(5 Suppl):S259-61 [14576646.001]
  • [Cites] Toxic Rep Ser. 2000 Apr;(61):1-53, A1-13 [11803700.001]
  • [Cites] Biometrics. 1971 Mar;27(1):103-17 [5547548.001]
  • [Cites] Biometrics. 1972 Jun;28(2):519-31 [5037867.001]
  • [Cites] Biometrics. 1988 Jun;44(2):417-31 [3390507.001]
  • [Cites] Fundam Appl Toxicol. 1989 May;12(4):731-7 [2744275.001]
  • [Cites] Ren Fail. 1991;13(4):211-25 [1780490.001]
  • [Cites] Toxicol Pathol. 1993;21(2):206-18 [8210943.001]
  • [Cites] Environ Health Perspect. 1993 Dec;101 Suppl 5:115-20 [7516872.001]
  • [Cites] Toxicol Pathol. 1994 Sep-Oct;22(5):457-72 [7899775.001]
  • [Cites] Toxicol Pathol. 1997 May-Jun;25(3):256-63 [9210256.001]
  • [Cites] Toxicol Pathol. 1999 Jul-Aug;27(4):383-94 [10485818.001]
  • [Cites] Toxicol Pathol. 1998 Jan-Feb;26(1):104-12 [9502392.001]
  • [Cites] Contact Dermatitis. 2001 Mar;44(3):188 [11217999.001]
  • [Cites] Toxicol Pathol. 2002 Nov-Dec;30(6):681-6 [12512869.001]
  • [Cites] Australas J Dermatol. 2001 Nov;42(4):257-9 [11903157.001]
  • [Cites] Bioorg Med Chem. 2004 May 15;12(10):2759-72 [15110857.001]
  • (PMID = 17187913.001).
  • [ISSN] 0278-6915
  • [Journal-full-title] Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • [ISO-abbreviation] Food Chem. Toxicol.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z99 ES999999
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Benzophenones; 0 / Photosensitizing Agents; 701M4TTV9O / benzophenone
  • [Other-IDs] NLM/ NIHMS21944; NLM/ PMC1936973
  •  go-up   go-down


7. Terao H, Matsumoto T, Umemoto S, Onuki T, Kobayashi K, Ohgo Y, Nogcchi S, Kishi H, Tsuura Y, Nagashima Y: [Metanephric adenoma: report of two cases]. Hinyokika Kiyo; 2008 Sep;54(9):599-602
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Metanephric adenoma: report of two cases].
  • We report 2 cases of metanephric adenoma a rare form of adenoma.
  • One case occurred in a 54-year-old male preoperatively diagnosed with renal cell carcinoma who underwent left partial nephrectomy for a tumor 2 cm in size.
  • Thus, the patient was diagnosed with metanephric adenoma.
  • The other case occurred in a 40-year-old male who underwent left nephroureterectomy for carcinoma of the renal pelvis.
  • Carcinoma of the left renal pelvis was diagnosed as pT3N0M0.
  • Incidental micronodules 2 mm in size and consisting of immature tubular structures were noted in the renal cortex.
  • In immunohistochemical staining, tumor cells were positive for CD57 and WT-1, and the patient was diagnosed with metanephric adenoma.
  • The aforementioned tumors frequently occur in middle-aged women and are often well-defined tumors that project from the renal surface outwards.
  • On angiography, they have a hypovascular pattern and resemble papillary renal carcinoma.
  • Preoperative differentiation of renal cell carcinoma and nephroblastoma is difficult.
  • [MeSH-major] Adenoma / diagnosis. Kidney Neoplasms / diagnosis
  • [MeSH-minor] Adult. Antigens, CD57 / analysis. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Kidney Pelvis. Male. Middle Aged. Neoplasm Staging. Nephrectomy. Tomography, X-Ray Computed. Ureter / surgery. WT1 Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18975573.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antigens, CD57; 0 / Biomarkers, Tumor; 0 / WT1 Proteins
  •  go-up   go-down


8. Liniger B, Wolf RW, Fleischmann A, Kluwe W: Local resection of metanephric adenoma with kidney preservation. J Pediatr Surg; 2009 Aug;44(8):E21-3
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Local resection of metanephric adenoma with kidney preservation.
  • Metanephric adenoma (MA) is a rare renal neoplasm present at any age.
  • Today, 2 1/2 years after surgery, we can document a favorable clinical course and normal ultrasound findings in the follow-up of the operated kidney.
  • [MeSH-major] Adenoma / surgery. Kidney Neoplasms / surgery. Nephrectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19635287.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


9. Schmelz HU, Stoschek M, Schwerer M, Danz B, Hauck EW, Weidner W, Sparwasser C: Metanephric adenoma of the kidney: case report and review of the literature. Int Urol Nephrol; 2005;37(2):213-7
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma of the kidney: case report and review of the literature.
  • Metanephric adenoma is a rare tumor of the kidney.
  • So far metanephric adenomas were considered to be benign, slowly growing and non-metastasizing tumors with an excellent prognosis.
  • Only recently two cases of metastasized metanephric adenomas were published.
  • We report the case of a 42 year old male with metanephric adenoma.
  • Current literature concerning metanephric adenoma is reviewed.
  • [MeSH-major] Adenoma / diagnosis. Kidney Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16142545.001).
  • [ISSN] 0301-1623
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Hungary
  • [Number-of-references] 32
  •  go-up   go-down


10. Denzinger S, Burger M, Hartmann A, Hofstaedter F, Wieland WF, Ganzer R: Spontaneous rupture of a benign giant adrenal adenoma. APMIS; 2007 Apr;115(4):381-4
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous rupture of a benign giant adrenal adenoma.
  • We report on a 50-year-old patient with a giant benign adenoma of the adrenal cortex, which ruptured spontaneously, leading to life-threatening retroperitoneal hemorrhage.
  • Following emergency adrenalectomy with sparing of the ipsilateral kidney, an adenoma of the adrenal cortex with a diameter of 18 cm and a weight of 1400 g was found.
  • A detailed literature search showed this to be the largest benign tumor of the adrenal cortex described so far.
  • We discuss the diagnosis and treatment of this unusual tumor.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Adrenocortical Adenoma / diagnosis
  • [MeSH-minor] Humans. Middle Aged. Rupture, Spontaneous / diagnosis. Rupture, Spontaneous / pathology. Rupture, Spontaneous / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17504308.001).
  • [ISSN] 0903-4641
  • [Journal-full-title] APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • [ISO-abbreviation] APMIS
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


11. Bosco M, Galliano D, La Saponara F, Pacchioni D, Bussolati G: Cytologic features of metanephric adenoma of the kidney during pregnancy: a case report. Acta Cytol; 2007 May-Jun;51(3):468-72
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytologic features of metanephric adenoma of the kidney during pregnancy: a case report.
  • BACKGROUND: Metanephric adenoma (MA) is a relatively rare neoplasm derived from metanephric blastema and composed of well-differentiated epithelial nephroblastic cells.
  • In view of its invariably benign clinical outcome, a preoperative diagnosis of this tumor could be of critical importance.
  • Since computed tomography and ultrasound imaging are not per se sufficient to unequivocally distinguish between MA and malignant neoplasms, fine needle aspiration cytology (FNAC) could be the only accurate method to establish a preoperative diagnosis of this tumor.
  • Transabdominal ultrasound examination disclosed a mass in her left kidney.
  • These cytologic and immunocytochemicalfindings led to a preoperative diagnosis of MA.
  • After delivery, the diagnosis was confirmed on the surgical specimen.
  • CONCLUSION: A diagnosis of MA could be established by FNAC supported by immunocytochemical analysis.
  • The present case illustrates the clinical impact that this diagnosis could have on patient management.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology. Pregnancy Complications, Neoplastic / pathology

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17536558.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Lara C, Porras V, Jurado P, Arredondo F: [Metanephric adenoma. Case report]. Arch Esp Urol; 2007 Nov;60(9):1.122-4
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Metanephric adenoma. Case report].
  • [Transliterated title] Adenoma metanéfrico. Presentación de un caso.
  • OBJECTIVE: Metanephric adenoma is an unfrequent renal neoplasm, usually asymptomatic.
  • Differential diagnosis with other renal tumors has to be performed.
  • METHODS/RESULTS: We report the case of a 67 years old woman with a metanephric adenoma.
  • At one end of the pathologic spectrum are the metanephric adenomas.
  • These tumors usually behave in a benign fashion.
  • It is important to differentiate metanephric adenoma from clinically aggressive renal tumors.
  • [MeSH-major] Adenoma / diagnosis. Kidney Neoplasms / diagnosis
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18077869.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


13. Sokolova IA, Matsko DE, Hes O, Michal M: [Mucinous tubular and spindle-cell carcinoma of the kidney]. Arkh Patol; 2006 Jul-Aug;68(4):14-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Mucinous tubular and spindle-cell carcinoma of the kidney].
  • 4 cases (2 males and 2 females) of mucinous tubular and spindle-cell carcinoma of the kidney were studied.
  • Microscopically, this tumor comprised two major cell populations.
  • Only one tumor had both cell components.
  • Mucinous tubular and spindle-cell carcinoma of the kidney should be differentiated from angiomyolipoma with the preponderance of a leiomyomatous component, renal smooth muscle neoplasms, metanephrotic adenoma, and renal cell carcinoma with sarcomatoid differentiation.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Carcinoma, Renal Cell / diagnosis. Kidney Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Female. Humans. Immunohistochemistry. Kidney Tubules / pathology. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16986488.001).
  • [ISSN] 0004-1955
  • [Journal-full-title] Arkhiv patologii
  • [ISO-abbreviation] Arkh. Patol.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


14. Frickmann H, Jungblut S, Bargon J, Willenbrock K, Störkel S, Hanke P: [Villous adenoma of the renal pelvis and ureter]. Urologe A; 2006 Nov;45(11):1435-7
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Villous adenoma of the renal pelvis and ureter].
  • [Transliterated title] Villöses Adenom des Nierenbeckens und Ureters.
  • Villous adenomas of the urinary tract are extremely rare tumours belonging to the adenoepithelial metaplasias.
  • We describe the case of an 85-year-old female patient suffering from a villous adenoma of the renal pelvis and ureter.
  • [MeSH-major] Adenoma, Villous / diagnosis. Carcinoma in Situ / diagnosis. Kidney Neoplasms / diagnosis. Kidney Pelvis. Neoplasms, Multiple Primary / diagnosis. Ureteral Neoplasms / diagnosis
  • [MeSH-minor] Aged, 80 and over. Diagnosis, Differential. Female. Humans. Nephrectomy. Tomography, X-Ray Computed. Ultrasonography. Ureter / pathology. Ureter / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1999 Jul;23(7):764-71 [10403298.001]
  • [Cites] Vopr Onkol. 1965;11(8):105-6 [5887831.001]
  • [Cites] Adv Anat Pathol. 2000 Mar;7(2):79-84 [10721414.001]
  • [Cites] Hum Pathol. 2002 Feb;33(2):236-41 [11957151.001]
  • [Cites] Urology. 2002 Aug;60(2):344 [12137843.001]
  • [Cites] Pathol Res Pract. 2001;197(7):507-13 [11482582.001]
  • [Cites] J Urol Nephrol (Paris). 1967 Dec;73(12):947 [5589231.001]
  • (PMID = 16900367.001).
  • [ISSN] 0340-2592
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


15. Torres Gómez FJ, Torres Olivera FJ, García Escudero A: [Predominantly cystic renal metanephric adenoma. Case report]. Arch Esp Urol; 2006 Jan-Feb;59(1):90-3
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Predominantly cystic renal metanephric adenoma. Case report].
  • [Transliterated title] Adenoma metanéfrico renal de predominio quístico. A propósito de un caso.
  • OBJECTIVES: Metanephric adenoma is a relatively unfrequent asymptomatic embryogenic renal tumor which is generally diagnosed by an abdominal diagnostic tests indicated for other reasons.
  • Differential diagnosis with benign and malignant tumors has to be performed.
  • METHODS/RESULTS: We report one case of metanephric adenoma with intense necrotic-hemorrhagic and cystic changes with a size not previously referred in the literature.
  • CONCLUSIONS: Cystic and hemorrhagic changes in benign renal tumors make differential diagnosis with malignant tumors mandatory Surgery is necessary in almost all cases and histologic study will give the diagnosis.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16568702.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


16. Kummerfeld M, Knieriem A, Wohlsein P: [Osteomyelitis and papillary renal adenoma in a red panda (Ailurus fulgens fulgens)]. Dtsch Tierarztl Wochenschr; 2008 Nov;115(11):421-5
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Osteomyelitis and papillary renal adenoma in a red panda (Ailurus fulgens fulgens)].
  • [Transliterated title] Osteomyelitis und papilläres renales Adenom bei einem Kleinen Pandabären (Ailurus fulgens fulgens).
  • Additionally, in the kidney a papillary renal adenoma was found.
  • Immunohistochemistry revealed an expression of cytokeratins 8 and/or 19 indicating an origin from the renal tubular epithelium.
  • [MeSH-major] Carcinoma, Renal Cell / veterinary. Kidney Neoplasms / veterinary. Osteomyelitis / veterinary. Ursidae

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19024549.001).
  • [ISSN] 0341-6593
  • [Journal-full-title] DTW. Deutsche tierärztliche Wochenschrift
  • [ISO-abbreviation] DTW. Dtsch. Tierarztl. Wochenschr.
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


17. Amin W, Parwani AV: Nephrogenic adenoma. Pathol Res Pract; 2010 Oct 15;206(10):659-62
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for nephrogenic adenoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nephrogenic adenoma.
  • Nephrogenic adenoma is an uncommon benign lesion.
  • The proposal that nephrogenic adenoma originates from the implantation of exfoliated renal tubular cells is lately gaining wider acceptance.
  • The role of immunohistochemistry cannot be undermined in the diagnosis of nephrogenic adenoma, although histological diagnosis is usually conclusive.
  • The possibility of nephrogenic adenoma should always be in the differential diagnosis when evaluating patients with predisposed urinary tract symptoms.
  • [MeSH-major] Adenoma / pathology. Kidney Tubules / pathology. Urologic Neoplasms / pathology
  • [MeSH-minor] Cell Transformation, Neoplastic / pathology. Diagnosis, Differential. Disease Progression. Humans. Immunohistochemistry. Predictive Value of Tests. Recurrence. Treatment Outcome. Urine / cytology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier GmbH. All rights reserved.
  • (PMID = 20619548.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  •  go-up   go-down


18. Inoue K, Shibutani M, Masutomi N, Toyoda K, Takagi H, Takahashi M, Fujimoto H, Hirose M, Nishikawa A: One-year chronic toxicity of madder color in F344 rats--induction of preneoplastic/neoplastic lesions in the kidney and liver. Food Chem Toxicol; 2008 Oct;46(10):3303-10
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] One-year chronic toxicity of madder color in F344 rats--induction of preneoplastic/neoplastic lesions in the kidney and liver.
  • Relative weights of the liver were significantly increased from 1.0% in both sexes, and those of the kidney were significantly increased from 1.0% in males and from 0.2% in females.
  • Histopathologically, atypical renal tubule hyperplasias were increased at 1.0% or higher in both sexes in association with increase of cell proliferative activity in the tubules.
  • A renal cell adenoma was observed in a male rat receiving 5.0% MC.
  • In addition, glutathione S-transferase placental form-positive liver cell foci were significantly increased at 5.0% in both sexes.
  • These results indicate that MC has chronic toxicity targeting kidney, liver and blood cells.
  • Moreover, the results strongly suggest that MC may have the carcinogenic potential in the kidney and the liver.
  • [MeSH-major] Kidney Neoplasms / chemically induced. Liver Neoplasms / chemically induced. Plant Extracts / administration & dosage. Plant Extracts / toxicity. Precancerous Conditions / chemically induced. Rubia / toxicity
  • [MeSH-minor] Animals. Cell Proliferation. Dose-Response Relationship, Drug. Drug Administration Schedule. Female. Kidney / cytology. Male. Rats. Rats, Inbred F344. Toxicity Tests, Chronic

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18723070.001).
  • [ISSN] 0278-6915
  • [Journal-full-title] Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • [ISO-abbreviation] Food Chem. Toxicol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Plant Extracts; 0 / madder color
  •  go-up   go-down


19. Fromont G, Barcat L, Gaudin J, Irani J: Revisiting the immunophenotype of nephrogenic adenoma. Am J Surg Pathol; 2009 Nov;33(11):1654-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Revisiting the immunophenotype of nephrogenic adenoma.
  • Nephrogenic adenoma (NA) is a rare benign lesion of the urinary tract.
  • Although its histogenesis is still debated, several reports suggest that the lesion has a renal tubular cell origin or differentiation.
  • Because all the previous studies have used an avidin-biotin (AB) detection procedure, and because cells with tubular renal differentiation are likely to contain a high level of endogenous biotin, we investigated in NA the expression of several markers including AMACR, using both AB and biotin-free detection systems.
  • We assessed the expression of p63, cytokeratins 7 and 20, CD10 (proximal tubule marker), MUC1 (distal tubule marker), PAX2, and AMACR on 14 NAs (from 6 patients) grouped on a tissue microarray.
  • The tissue microarray also included renal, urothelial, and prostate tissues.
  • Detection with the AB procedure leads to nonspecific staining in kidney samples and NA.
  • These findings provide supporting evidence that NA has the differentiation of distal renal tubules, and strongly suggest that AMACR, when detected with a biotin-free procedure, can be used as a reliable marker for distinguishing NA from prostate cancer.
  • [MeSH-major] Adenoma / immunology. Immunophenotyping / methods. Urologic Neoplasms / immunology
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / metabolism. Child. Diagnosis, Differential. Female. Fluorescent Antibody Technique, Indirect. Humans. Kidney Tubules / enzymology. Male. Middle Aged. Prostatic Neoplasms / diagnosis. Racemases and Epimerases / metabolism. Tissue Array Analysis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19730362.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 5.1.- / Racemases and Epimerases; EC 5.1.99.4 / alpha-methylacyl-CoA racemase
  •  go-up   go-down


20. Szponar A, Yusenko MV, Kovacs G: High-resolution array CGH of metanephric adenomas: lack of DNA copy number changes. Histopathology; 2010 Jan;56(2):212-6
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-resolution array CGH of metanephric adenomas: lack of DNA copy number changes.
  • AIMS: Previous karyotyping and fluorescence in situ hybridization analysis of metanephric adenomas (MAs) has yielded controversial data.
  • METHODS AND RESULTS: DNA extracted from paraffin blocks of six metanephric adenomas was hybridized onto Agilent oligoarrays with approximately 43,000 in situ synthesized 60-mer oligonucleotide probes that span coding and non-coding sequences with an average spatial resolution of approximately 35 kb.
  • None of the metanephric adenomas showed DNA copy number changes.
  • To confirm our results, DNA extracted from the paraffin block of a chromophobe renal cell carcinoma (RCC) was simultaneously hybridized to one of the four arrays on the same slides as an internal control.
  • CONCLUSIONS: Our high-resolution oligoarray analysis indicates that metanephric adenomas lack DNA copy number alterations.
  • This finding may help to differentiate between metanephric adenomas from Wilms' tumour and papillary renal cell adenoma with overlapping phenotype.
  • [MeSH-major] Adenoma / genetics. DNA Copy Number Variations. Kidney Neoplasms / genetics
  • [MeSH-minor] Carcinoma, Renal Cell / genetics. Carcinoma, Renal Cell / pathology. Comparative Genomic Hybridization. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20102400.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


21. Kohashi K, Oda Y, Nakamori M, Yamamoto H, Tamiya S, Toubo T, Kinoshita Y, Tajiri T, Taguchi T, Tsuneyoshi M: Multifocal metanephric adenoma in childhood. Pathol Int; 2009 Jan;59(1):49-52
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multifocal metanephric adenoma in childhood.
  • Metanephric adenoma is the most commonly occurring member of the metanephric tumor family, which also includes metanephric adenofibroma and metanephric stromal tumor.
  • Reported herein is the case of a 9-year-old boy with multifocal metanephric adenoma.
  • Other histologically similar tumors are papillary renal cell carcinoma and nephroblastoma, and it is necessary to distinguish metanephric adenoma from those tumors because of malignancy.
  • In contrast to those tumors, metanephric adenoma has inconspicuous nucleoli, loss of CK7 and EMA expression, and no mitotic figures.
  • Thus, the histological and immunohistochemical features of the present case were compatible with metanephric adenoma.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19121092.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  •  go-up   go-down


22. Csupor E, Toth E, Meszaros S, Ferencz V, Szucs J, Lakatos P, Horányi J, Perner F, Horvath C: Is there any connection between the presence of kidney stones in primary hyperparathyroidism and the location of an underlying adenoma? Exp Clin Endocrinol Diabetes; 2005 May;113(5):257-61
Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is there any connection between the presence of kidney stones in primary hyperparathyroidism and the location of an underlying adenoma?
  • The majority of the patients with primary hyperparathyroidism (pHPT) recurrently produce kidney stones, while the rest have other clinical manifestations.
  • The aim of this study was to examine the possibility of an association between the presence of kidney stones and the location of an underlying adenoma.
  • Kidney stones were found in 55 cases and other clinical symptoms in 35 cases.
  • In 50 of the 55 patients (91 %) with kidney stones, the adenoma was located in the left inferior parathyroid gland (chi2 = 67.5, p < 0.00,001), while in 24 of the 35 patients (69 %) without kidney stones, the adenoma was in the right inferior parathyroid gland (chi2 = 43.9, p < 0.0001).
  • These results suggest that the location of the adenoma may influence the presence of kidney stones in pHPT.
  • [MeSH-major] Adenoma / pathology. Hyperparathyroidism / complications. Kidney Calculi / complications. Parathyroid Neoplasms / pathology

  • Genetic Alliance. consumer health - Hyperparathyroidism, primary.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15926110.001).
  • [ISSN] 0947-7349
  • [Journal-full-title] Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
  • [ISO-abbreviation] Exp. Clin. Endocrinol. Diabetes
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Parathyroid Hormone; SY7Q814VUP / Calcium
  •  go-up   go-down


23. Al-Mashat F, Sibiany A, Faleh D, Kary K, Alfi AY, El-Lakany MM: Mediastinal parathyroid adenoma. Saudi J Kidney Dis Transpl; 2009 Sep;20(5):826-30
Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mediastinal parathyroid adenoma.
  • In the first case the adenoma was removed through a transcervical incision and in the second case the supernumerary adenoma was removed through sternotomy.
  • [MeSH-major] Adenoma / surgery. Parathyroid Neoplasms / surgery. Parathyroidectomy. Sternum / surgery

  • Hazardous Substances Data Bank. TECHNETIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19736482.001).
  • [ISSN] 1319-2442
  • [Journal-full-title] Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
  • [ISO-abbreviation] Saudi J Kidney Dis Transpl
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Saudi Arabia
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Parathyroid Hormone; 0 / Radiopharmaceuticals; 0 / Thallium Radioisotopes; 7440-26-8 / Technetium; 971Z4W1S09 / Technetium Tc 99m Sestamibi; SY7Q814VUP / Calcium
  •  go-up   go-down


24. Pittavini L, De Gaetano A, Solano G, Losito A: Resistant arterial hypertension: association with syncronous kidney cancer and adrenal adenoma. J Nephrol; 2010 Sep-Oct;23(5):614-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resistant arterial hypertension: association with syncronous kidney cancer and adrenal adenoma.
  • The coexistence of renal cancer and adrenal adenoma is rare.
  • We report the case of a 60-year-old patient with synchronous hypernephroma and adrenal adenoma.
  • Removal of the affected kidney cured the hypertension and normalized the plasma renin activity (PRA) and circulating aldosterone.
  • This suggests that the coexistence of kidney cancer and adrenal adenoma may be a curable cause of resistant hypertension.
  • [MeSH-major] Adenoma / complications. Adrenal Gland Neoplasms / complications. Carcinoma, Renal Cell / complications. Hypertension / etiology. Kidney Neoplasms / complications. Neoplasms, Multiple Primary / complications


25. Sanders JM, Bucher JR, Peckham JC, Kissling GE, Hejtmancik MR, Chhabra RS: Carcinogenesis studies of cresols in rats and mice. Toxicology; 2009 Mar 4;257(1-2):33-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A marginally increased incidence of renal tubule adenoma was observed in the 15,000-ppm-exposed rats.
  • No increased incidence of hyperplasia of the renal tubules was observed; however, a significantly increased incidence of hyperplasia of the transitional epithelium associated with an increased incidence of nephropathy was observed at the high exposure concentration.
  • The only significantly increased incidence of a neoplastic lesion related to cresol exposure observed in these studies was that of squamous cell papilloma in the forestomach of 10,000-ppm-exposed mice.
  • [MeSH-major] Carcinogenicity Tests. Carcinogens / toxicity. Cresols / toxicity. Kidney Neoplasms / pathology. Neoplasms / chemically induced
  • [MeSH-minor] Adenoma / chemically induced. Adenoma / pathology. Animals. Body Weight / drug effects. Dose-Response Relationship, Drug. Eating / drug effects. Female. Gastric Mucosa / drug effects. Gastric Mucosa / pathology. Kidney Tubules / drug effects. Kidney Tubules / pathology. Male. Mice. Papilloma / chemically induced. Papilloma / pathology. Rats. Rats, Inbred F344. Stomach Neoplasms / chemically induced. Stomach Neoplasms / pathology. Time Factors

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Environ Health Perspect. 1990 Apr;85:177-86 [2200661.001]
  • [Cites] Fundam Appl Toxicol. 1989 May;12(4):731-7 [2744275.001]
  • [Cites] Forensic Sci Int. 1990 Aug;47(1):21-9 [2210550.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 1991;31:621-52 [2064387.001]
  • [Cites] Food Chem Toxicol. 1992 Apr;30(4):333-40 [1628870.001]
  • [Cites] Environ Health Perspect. 1993 Oct;101 Suppl 3:341-4 [8143642.001]
  • [Cites] Chem Res Toxicol. 1995 Jan-Feb;8(1):55-60 [7703367.001]
  • [Cites] Pharmacology. 1995 Sep;51(3):195-204 [7501706.001]
  • [Cites] J Chromatogr B Biomed Sci Appl. 1997 Dec 5;703(1-2):105-13 [9448067.001]
  • [Cites] Vet Hum Toxicol. 1998 Dec;40(6):341-3 [9830694.001]
  • [Cites] Bull Environ Contam Toxicol. 1999 Sep;63(3):399-406 [10475920.001]
  • [Cites] J Dairy Sci. 2005 Jan;88(1):7-12 [15591361.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Mar 25;817(2):309-17 [15687000.001]
  • [Cites] Drug Metab Dispos. 2005 Dec;33(12):1867-76 [16174805.001]
  • [Cites] Environ Sci Pollut Res Int. 2006 Mar;13(2):83-9 [16612896.001]
  • [Cites] Chem Res Toxicol. 2001 Jan;14(1):25-33 [11170505.001]
  • [Cites] J Agric Food Chem. 2001 Mar;49(3):1382-7 [11312868.001]
  • [Cites] J Contam Hydrol. 2001 Dec 15;53(3-4):233-67 [11820472.001]
  • [Cites] Toxicol Lett. 2002 Mar 24;129(1-2):65-76 [11879975.001]
  • [Cites] J Agric Food Chem. 2002 Mar 27;50(7):2016-21 [11902950.001]
  • [Cites] Forensic Sci Int. 2002 Mar 28;126(1):77-81 [11955837.001]
  • [Cites] Toxicol Pathol. 2002 Nov-Dec;30(6):681-6 [12512869.001]
  • [Cites] Anal Bioanal Chem. 2003 Jun;376(3):413-21 [12732922.001]
  • [Cites] Nephrol Dial Transplant. 2003 Jul;18(7):1299-306 [12808165.001]
  • [Cites] Biodegradation. 2003 Aug;14(4):297-307 [12948059.001]
  • [Cites] Leg Med (Tokyo). 2004 Mar;6(1):32-40 [15177071.001]
  • [Cites] Med Sci Law. 1975 Jan;15(1):65-6 [1219312.001]
  • [Cites] Am J Clin Nutr. 1976 Dec;29(12):1448-54 [826152.001]
  • [Cites] Toxicol Appl Pharmacol. 1977 Nov;42(2):417-23 [595018.001]
  • [Cites] Br J Ind Med. 1981 May;38(2):194-7 [7236546.001]
  • [Cites] J Natl Cancer Inst. 1983 Feb;70(2):343-52 [6571941.001]
  • [Cites] J Hyg Epidemiol Microbiol Immunol. 1984;28(2):129-38 [6470477.001]
  • [Cites] Biometrics. 1988 Jun;44(2):417-31 [3390507.001]
  • [Cites] Environ Health Perspect. 1990 Apr;85:187-208 [2200662.001]
  • (PMID = 19114085.001).
  • [ISSN] 0300-483X
  • [Journal-full-title] Toxicology
  • [ISO-abbreviation] Toxicology
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z99 ES999999
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Carcinogens; 0 / Cresols
  • [Other-IDs] NLM/ NIHMS104529; NLM/ PMC2826171
  •  go-up   go-down


26. Chan AP, Wan IY, Wong RH, Hsin MK, Underwood MJ: Robot-assisted excision of ectopic mediastinal parathyroid adenoma. Asian Cardiovasc Thorac Ann; 2010 Feb;18(1):65-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Robot-assisted excision of ectopic mediastinal parathyroid adenoma.
  • Robot-assisted excision of an ectopic parathyroid adenoma in the superior mediastinum was performed in a 57-year-old man.
  • Identification of the ectopic parathyroid adenoma was facilitated by the 3-dimensional images of the da Vinci robotic system, and resection was achieved using EndoWrist instruments.
  • Robot-assisted excision of parathyroid adenoma located in the relatively inaccessible superior mediastinum proved to be feasible.
  • [MeSH-major] Adenoma / surgery. Mediastinum / surgery. Parathyroid Neoplasms / surgery. Parathyroidectomy / methods. Robotics / methods
  • [MeSH-minor] Humans. Imaging, Three-Dimensional / methods. Kidney Failure, Chronic / complications. Male. Middle Aged. Tomography, X-Ray Computed / methods. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20124300.001).
  • [ISSN] 1816-5370
  • [Journal-full-title] Asian cardiovascular & thoracic annals
  • [ISO-abbreviation] Asian Cardiovasc Thorac Ann
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


27. Bhutta MF, Dunk L, Molyneux AJ, Tewary A: Parotid pleomorphic adenoma with solitary renal metastasis. Br J Oral Maxillofac Surg; 2010 Jan;48(1):61-3
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Parotid pleomorphic adenoma with solitary renal metastasis.
  • We present a rare case of renal metastasis of a recurrent pleomorphic adenoma of the parotid gland in an elderly woman.
  • Metastasising pleomorphic adenoma shows malignant clinical behaviour, and although it appears histologically benign, there may be unknown molecular features that determine its unusual ability to spread.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Kidney Neoplasms / secondary. Parotid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 19386401.001).
  • [ISSN] 1532-1940
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


28. Algaba F: Renal adenomas: pathological differential diagnosis with malignant tumors. Adv Urol; 2008;:974848

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal adenomas: pathological differential diagnosis with malignant tumors.
  • The renal adenomas can be confused by imaging diagnosis with malignant renal tumors, but there are also real biological dilemmas to determine their behavior.
  • The consensus decisions are the following. (1) The adenoma of clear cells is not accepted, instead it is considered that all the clear-cell tumors are carcinomas, with greater or lesser aggressiveness. (2) Among the papillary neoplasms the WHO 2004 renal cell tumors classification are considered as papillary adenomas tumors with a maximum diameter of 5 mm and may represent a continuum biological process to papillary renal cell carcinoma.
  • The papillary adenomas associated with End-kidney and/or acquired cystic disease may have a different pathogenesis. (3) To consider a tumor as an oncocytoma the size is not important, only the cytological features, microscopic, ultrastructural, and immunohistochemically can help, but some chromosomal observations introduce some questions about its relation with the chromophobe renal cell carcinoma. (4) Finally, the metanephric adenoma, a tumor with some morphological similarity with the nephroblastoma must be considered in the renal adenomas diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Endourol. 2007 Aug;21(8):819-23 [17867935.001]
  • [Cites] Am J Surg Pathol. 2007 Apr;31(4):489-500 [17414095.001]
  • [Cites] Hum Pathol. 2007 Feb;38(2):239-46 [17056094.001]
  • [Cites] Urology. 2006 Oct;68(4):737-40 [17070344.001]
  • [Cites] Mod Pathol. 2006 Feb;19(2):218-24 [16424894.001]
  • [Cites] Am J Clin Pathol. 2006 Feb;125(2):217-22 [16393684.001]
  • [Cites] BJU Int. 2005 Dec;96(9):1275-9 [16287444.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Jul 1;152(1):23-8 [15193438.001]
  • [Cites] Hum Pathol. 2001 Jan;32(1):101-4 [11172302.001]
  • (PMID = 18846240.001).
  • [ISSN] 1687-6369
  • [Journal-full-title] Advances in urology
  • [ISO-abbreviation] Adv Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  • [Other-IDs] NLM/ PMC2563151
  •  go-up   go-down


29. Rahemtullah A, Oliva E: Nephrogenic adenoma: an update on an innocuous but troublesome entity. Adv Anat Pathol; 2006 Sep;13(5):247-55

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nephrogenic adenoma: an update on an innocuous but troublesome entity.
  • Nephrogenic adenoma (NA) is a rare benign lesion of the urothelial tract that is typically preceded by some form of genitourinary insult.
  • Although generally presumed to be a metaplastic process of the urothelium, recent evidence suggests that NA may in fact be derived from detached renal tubular cells implanting along the urothelial tract in previously injured areas, at least in cases associated with a kidney transplant.
  • Recognition of its characteristic patterns, and awareness of its unusual architectural and cytologic features, is key to making the diagnosis of NA and distinguishing this lesion from malignant neoplasms occurring at the same sites, in particular, clear cell carcinoma, nested or microcystic variants of urothelial carcinoma and prostatic adenocarcinoma.
  • Although straightforward in most cases, the correct diagnosis may be difficult to make on limited tissue samples.
  • Clinicopathologic correlation with careful attention to morphology remains the pillar in establishing the correct diagnosis.
  • [MeSH-major] Adenoma / pathology. Urologic Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma, Clear Cell / pathology. Carcinoma, Signet Ring Cell / pathology. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Prostatic Neoplasms / pathology. Urothelium / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16998318.001).
  • [ISSN] 1072-4109
  • [Journal-full-title] Advances in anatomic pathology
  • [ISO-abbreviation] Adv Anat Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 64
  •  go-up   go-down


30. TAIPAI Study Group, Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH, Ho YL, Lin WC, Wang SM, Huang KH, Hung KY, Kao TW, Lin SL, Yen RF, Chen YM, Hsieh BS, Wu KD: Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis; 2009 Oct;54(4):665-73
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
  • BACKGROUND: Autonomous secretion of aldosterone in patients with primary aldosteronism increases glomerular filtration rate and causes kidney damage.
  • The influence of a mild decrease in kidney function on residual hypertension after adrenalectomy is unexplored.
  • 150 patients (61 men; overall mean age, 47.2 +/- 11.6 years) with a diagnosis of aldosterone-producing adenoma had undergone unilateral adrenalectomy at National Taiwan University Hospital from July 1999 to January 2007.
  • CONCLUSIONS: Two-thirds of patients with aldosterone-producing adenoma were cured of hypertension by means of unilateral adrenalectomy.
  • Kidney function impairment, even mild, appears to be associated with a high incidence of postsurgery residual hypertension.
  • [MeSH-major] Adenoma / physiopathology. Adrenal Cortex Neoplasms / physiopathology. Adrenalectomy. Aldosterone / blood. Glomerular Filtration Rate. Hypertension / physiopathology. Kidney / physiopathology
  • [MeSH-minor] Adult. Blood Pressure. Creatinine / blood. Female. Humans. Hyperaldosteronism / blood. Hyperaldosteronism / etiology. Hyperaldosteronism / metabolism. Hyperaldosteronism / physiopathology. Kidney Function Tests. Male. Middle Aged. Odds Ratio. Retrospective Studies. Severity of Illness Index

  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Am J Kidney Dis. 2009 Oct;54(4):594-7 [19781452.001]
  • (PMID = 19628318.001).
  • [ISSN] 1523-6838
  • [Journal-full-title] American journal of kidney diseases : the official journal of the National Kidney Foundation
  • [ISO-abbreviation] Am. J. Kidney Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone; AYI8EX34EU / Creatinine
  • [Investigator] Wu VC; Lin YH; Ho YL; Chang HW; Lin LY; Hu FC; Liu KL; Wang SM; Huang KH; Chang FC; Chen YM; Kuo CC; Chueh SC; Lu CC; Chang FC; Liao SC; Yen RF; Lin WC; Hsieh BS; Wu KD; Hsien FF
  •  go-up   go-down


31. National Toxicology Program: Toxicology and carcinogenesis studies of methyl isobutyl ketone (Cas No. 108-10-1) in F344/N rats and B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser; 2007 Feb;(538):1-236
Hazardous Substances Data Bank. 2-HEXANONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the standard evaluation of the kidney, there were slightly increased incidences of renal tubule adenoma and renal tubule adenoma or carcinoma (combined) in males exposed to 900 or 1,800 ppm, and renal tubule carcinoma in males exposed to 1,800 ppm.
  • The incidences of renal tubule hyperplasia were also significantly increased in the 450 and 1,800 ppm males, and the severities were greater than in the chamber controls.
  • The incidences of transitional epithelial hyperplasia of the renal pelvis in males exposed to 900 or 1,800 ppm and mineralization of the renal papilla in all groups of exposed males were significantly increased.
  • In addition, two female rats exposed to 1,800 ppm had renal mesenchymal tumors.
  • In the extended evaluation of the kidney, renal tubule adenomas and renal tubule hyperplasia occurred in all groups of exposed male rats.
  • In the combined single and step section analysis, the incidences of renal tubule adenoma and renal tubule adenoma or carcinoma (combined) were significantly increased in males exposed to 1,800 ppm.
  • The incidences of renal tubule hyperplasia were also significantly increased in all exposed groups of males.
  • There was a positive trend in the incidences of mononuclear cell leukemia in males, and the incidence in the 1,800 ppm group was significantly increased.
  • The incidences of hepatocellular adenoma and hepatocellular adenoma or carcinoma (combined) were significantly increased in males and females exposed to 1,800 ppm.
  • CONCLUSIONS: Under the conditions of these 2-year studies, there was some evidence of carcinogenic activity of methyl isobutyl ketone in male F344/N rats based on increased incidences of renal tubule neoplasms.
  • Increased incidences of mononuclear cell leukemia in 1,800 ppm male F344/N rats may have been related to methyl isobutyl ketone exposure.
  • There was equivocal evidence of carcinogenic activity of methyl isobutyl ketone in female F344/N rats based on the occurrence of renal mesenchymal tumors in the 1,800 ppm group.
  • Exposure to methyl isobutyl ketone resulted in nonneoplastic lesions of the kidney characteristic of alpha2u-globulin accumulation in male rats and nephropathy in female rats.
  • [MeSH-minor] Administration, Oral. Adrenal Glands / drug effects. Animals. Body Weight / drug effects. Female. Kidney / drug effects. Kidney / pathology. Kidney Neoplasms / chemically induced. Kidney Neoplasms / pathology. Leukemia, Myeloid / chemically induced. Leukemia, Myeloid / pathology. Liver / drug effects. Liver / pathology. Liver Neoplasms / chemically induced. Liver Neoplasms / pathology. Lung Neoplasms / chemically induced. Lung Neoplasms / pathology. Male. Mice. Mice, Inbred Strains. Occupational Exposure. Rats. Rats, Inbred F344. Water Supply

  • Hazardous Substances Data Bank. METHYL ISOBUTYL KETONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17557116.001).
  • [ISSN] 0888-8051
  • [Journal-full-title] National Toxicology Program technical report series
  • [ISO-abbreviation] Natl Toxicol Program Tech Rep Ser
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carcinogens; 0 / Environmental Pollutants; 0 / Solvents; 6QDY60NH6N / Methyl n-Butyl Ketone; U5T7B88CNP / methyl isobutyl ketone
  •  go-up   go-down


32. Miles LF, Wakeman CJ, Farmer KC: Giant villous adenoma presenting as McKittrick-Wheelock syndrome and pseudo-obstruction. Med J Aust; 2010 Feb 15;192(4):225-7
MedlinePlus Health Information. consumer health - Fluid and Electrolyte Balance.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant villous adenoma presenting as McKittrick-Wheelock syndrome and pseudo-obstruction.
  • McKittrick-Wheelock syndrome is a rare but recognised complication of hypersecretory rectosigmoid villous adenoma.
  • We report an unusual presentation of the syndrome associated with the development of acute pseudo-obstruction of the colon, presumably due to electrolyte dysfunction and acute renal failure.
  • [MeSH-major] Acute Kidney Injury / etiology. Adenoma, Villous / complications. Colonic Neoplasms / complications. Colonic Pseudo-Obstruction / etiology. Water-Electrolyte Imbalance / etiology
  • [MeSH-minor] Aged. Colonoscopy. Diagnosis, Differential. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Syndrome. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20170462.001).
  • [ISSN] 0025-729X
  • [Journal-full-title] The Medical journal of Australia
  • [ISO-abbreviation] Med. J. Aust.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


33. National Toxicology Program: NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies). Natl Toxicol Program Tech Rep Ser; 2010 Dec;(557):1-163
Hazardous Substances Data Bank. MYRCENE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Right kidney and liver weights of dosed males and females were generally significantly greater than those of the vehicle controls.
  • In special study rats evaluated on day 23, the incidences and severities of chronic progressive nephropathy (CPN) and renal tubule degeneration were increased in 2 g/kg males.
  • At the end of the 3-month study, the incidences of renal tubule necrosis were significantly increased in all dosed groups of males and females.
  • The right kidney weights of 1 g/kg females and the liver weights of females administered 0.5 or 1 g/kg were significantly increased.
  • All 1 g/kg male rats died before the end of the study due to renal toxicity.
  • In the standard evaluation of the kidney, the incidence of renal tubule adenoma was significantly increased in 0.5 g/kg male rats, and the combined incidences of renal tubule adenoma or carcinoma were significantly increased in 0.25 and 0.5 g/kg males.
  • In both the extended evaluation and the combined standard and extended evaluations, the incidences of renal tubule adenoma and the combined incidences of renal tubule adenoma or carcinoma were significantly increased in the 0.25 and 0.5 g/kg groups of males.
  • The incidences of renal tubule nephrosis (nephrosis) were markedly increased in all dosed groups of both sexes except in 0.25 g/kg females.
  • The incidences of hyperplasia of the transitional epithelium lining the pelvis and overlying the renal papilla were significantly increased in all dosed groups of males and females.
  • Liver neoplasms included hepatocellular adenoma and hepatocellular carcinoma in males and females and hepatoblastoma in males.
  • The incidences of hepatocellular hypertrophy were significantly increased in 0.5 g/kg males and females, as was the incidence of mixed cell focus in 0.5 g/kg females.
  • CONCLUSIONS: Under the conditions of these 2-year gavage studies, there was clear evidence of carcinogenic activity of beta-myrcene in male F344/N rats based on increased incidences of renal tubule neoplasms.
  • There was equivocal evidence of carcinogenic activity of beta-myrcene in female F344/N rats based on increased incidences of renal tubule adenoma.
  • There was clear evidence of carcinogenic activity of beta-myrcene in male B6C3F1 mice based on increased incidences of hepatocellular adenoma, hepatocellular carcinoma, and hepatoblastoma.
  • There was equivocal evidence of carcinogenic activity of beta-myrcene in female B6C3F1 mice based on marginally increased incidences of hepatocellular adenoma and carcinoma.
  • Administration of beta-myrcene induced nonneoplastic lesions in the kidney of male and female rats, nose of male rats, and liver of male and female mice.
  • [MeSH-major] Adenoma / chemically induced. Carcinoma, Hepatocellular / chemically induced. Hepatoblastoma / chemically induced. Kidney Neoplasms / chemically induced. Liver Neoplasms / chemically induced. Monoterpenes / toxicity. Neoplasms, Experimental / chemically induced
  • [MeSH-minor] Animals. Carcinogenicity Tests. Female. Humans. Kidney / drug effects. Kidney / pathology. Longevity / drug effects. Male. Mice. Mice, Inbred Strains. Mutagenicity Tests. Nose / drug effects. Nose / pathology. Rats. Rats, Inbred F344. Toxicity Tests, Chronic

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21415873.001).
  • [ISSN] 0888-8051
  • [Journal-full-title] National Toxicology Program technical report series
  • [ISO-abbreviation] Natl Toxicol Program Tech Rep Ser
  • [Language] eng
  • [Publication-type] Journal Article; Technical Report
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Monoterpenes; 123-35-3 / beta-myrcene
  • [Investigator] Chan PC; Cesta MF; Sills RC; Bishop JB; Bristol DW; Bucher JR; Chhabra RS; Foster PM; Herbert RA; Hooth MJ; King-Herbert AP; Kissling GE; Malarkey DE; Roycroft JH; Sanders JM; Smith CS; Travlos GS; Walker NJ; Witt KL
  •  go-up   go-down


34. Tanemoto M, Abe M, Satoh F, Abe T, Satoh H, Ito S: Mesangial proliferative glomerulonephritis with aldosterone-producing adenoma. Clin Exp Nephrol; 2007 Jun;11(2):164-7
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesangial proliferative glomerulonephritis with aldosterone-producing adenoma.
  • We describe a case of mesangial proliferative glomerulonephritis (MesPGN), the clinical symptoms of which were exacerbated by aldosterone-producing adenoma (APA).
  • A 45-year-old man, who had had a history of hypertension for several years, presented with renal derangement, with serum creatinine at its upper normal limit and with microhematuria and proteinuria.
  • [MeSH-major] Adenoma / complications. Adrenal Gland Neoplasms / complications. Glomerulonephritis, Membranoproliferative / complications
  • [MeSH-minor] Aldosterone / blood. Biopsy. Hematuria / etiology. Humans. Kidney Glomerulus / pathology. Male. Middle Aged. Proteinuria / etiology. Renin / blood

  • Genetic Alliance. consumer health - Glomerulonephritis.
  • Genetic Alliance. consumer health - Mesangial proliferative glomerulonephritis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Chronic Dis. 1958 Nov;8(5):587-95 [13587613.001]
  • [Cites] Am J Nephrol. 2005 Jan-Feb;25(1):1-12 [15644622.001]
  • [Cites] J Am Soc Nephrol. 2003 Jun;14(6):1578-83 [12761258.001]
  • [Cites] Nephron. 1999;82(3):205-13 [10395992.001]
  • [Cites] N Engl J Med. 2001 Sep 20;345(12 ):870-8 [11565519.001]
  • [Cites] Acta Med Scand. 1981;209(6):451-5 [7257863.001]
  • [Cites] Arch Intern Med. 1987 Jul;147(7):1289-93 [3606286.001]
  • [Cites] J Hypertens. 1998 May;16(5):635-43 [9797175.001]
  • [Cites] Kidney Int. 2004 Sep;66(3):890-4 [15327376.001]
  • [Cites] JAMA. 2002 Dec 18;288(23):2981-97 [12479763.001]
  • [Cites] Kidney Int. 1999 Mar;55(3):877-89 [10027924.001]
  • [Cites] Hypertension. 2000 Oct;36(4):561-8 [11040236.001]
  • [Cites] Kidney Int. 2004 Sep;66(3):905-8 [15327379.001]
  • [Cites] Hypertension. 2006 Aug;48(2):232-8 [16801482.001]
  • [Cites] N Engl J Med. 2001 Sep 20;345(12):861-9 [11565518.001]
  • [Cites] N Engl J Med. 1998 Dec 17;339(25):1828-34 [9854120.001]
  • [Cites] QJM. 2004 May;97(5):297-301 [15100424.001]
  • [Cites] Hypertension. 2000 May;35(5):1078-84 [10818068.001]
  • [Cites] Endocrinology. 2003 Jun;144(6):2208-13 [12746276.001]
  • [Cites] Kidney Int. 2004 Sep;66(3):920-3 [15327382.001]
  • [Cites] Clin Exp Pharmacol Physiol. 1997 Jul;24(7):532-5 [9248673.001]
  • [Cites] Kidney Int. 1999 Oct;56(4):1199-207 [10610410.001]
  • [Cites] Int J Urol. 2006 Jul;13(7):990-2 [16882069.001]
  • [Cites] N Engl J Med. 2002 Sep 5;347(10):738-48 [12213946.001]
  • [Cites] Kidney Int. 1996 Jan;49(1):168-73 [8770964.001]
  • (PMID = 17593517.001).
  • [ISSN] 1342-1751
  • [Journal-full-title] Clinical and experimental nephrology
  • [ISO-abbreviation] Clin. Exp. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone; EC 3.4.23.15 / Renin
  •  go-up   go-down


35. Lamprecht G, Gaco V, Turner JR, Natour D, Gregor M: Regulation of the intestinal anion exchanger DRA (downregulated in adenoma). Ann N Y Acad Sci; 2009 May;1165:261-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Regulation of the intestinal anion exchanger DRA (downregulated in adenoma).
  • DRA (downregulated in adenoma) is an intestinal chloride/bicarbonate exchanger that is functionally coupled to CFTR (cystic fibrosis transmembrane regulator) in the upper gastrointestinal tract to mediate chloride and bicarbonate secretion and to NHE3 (Na/H exchanger- isoform 3) in the lower gastrointestinal tract to mediate electroneutral NaCl absorption.
  • All three transport proteins possess PDZ domain binding motifs that facilitate binding to members of the NHERF (Na/H exchanger regulatory factor) family of adapter proteins [NHERF, E3KARP (NHE3 kinase A regulatory protein), PDZK1 (PDZ protein kidney 1) and IKEPP (intestinal and kidney enriched PDZ protein)].

  • Hazardous Substances Data Bank. SODIUM .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19538314.001).
  • [ISSN] 1749-6632
  • [Journal-full-title] Annals of the New York Academy of Sciences
  • [ISO-abbreviation] Ann. N. Y. Acad. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anions; 0 / Chloride-Bicarbonate Antiporters; 126880-72-6 / Cystic Fibrosis Transmembrane Conductance Regulator; 9NEZ333N27 / Sodium; EC 2.7.11.13 / Protein Kinase C
  •  go-up   go-down


36. Bozkurt SU, Erbarut I, Yazici C, Kaya H, Türkeri L: Nephrogenic adenoma of the ureter: case report. Int Urol Nephrol; 2007;39(1):65-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nephrogenic adenoma of the ureter: case report.
  • Nephrogenic adenoma is a rare metaplastic benign lesion of urothelium in response to genitourinary tract procedures, chronic infection, trauma, urinary calculi and immunosuppressive therapy after renal transplantation.
  • We report a case of nephrogenic adenoma arising from the lower end of the right ureter with clinical and radiological features suspicious of carcinoma.
  • [MeSH-major] Adenoma / pathology. Ureteral Neoplasms / pathology
  • [MeSH-minor] Humans. Keratin-7 / metabolism. Kidney Tubules / pathology. Magnetic Resonance Imaging. Male. Middle Aged. Urography. Urothelium / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17268911.001).
  • [ISSN] 0301-1623
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Hungary
  • [Chemical-registry-number] 0 / Keratin-7
  •  go-up   go-down


37. Kumar S, Mandal AK, Acharya NR, Kakkad N, Singh SK: Laparoscopic nephron-sparing surgery for metanephric adenoma. Surg Laparosc Endosc Percutan Tech; 2007 Dec;17(6):573-5
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic nephron-sparing surgery for metanephric adenoma.
  • Histologic examination of the mass was consistent with metanephric adenoma.
  • We are reporting this case of metanephric adenoma, being treated with laparoscopic partial nephrectomy.
  • [MeSH-major] Adenoma / surgery. Kidney Neoplasms / surgery. Laparoscopy / methods. Nephrectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18097330.001).
  • [ISSN] 1530-4515
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Galmiche L, Vasiliu V, Poirée S, Hélénon O, Casanova JM, Brousse N: [Diagnosis of renal metanephric adenoma: relevance of immunohistochemistry and biopsy]. Ann Pathol; 2007 Oct;27(5):365-8
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnosis of renal metanephric adenoma: relevance of immunohistochemistry and biopsy].
  • [Transliterated title] Diagnostic d'adénome métanéphrique rénal: Intérêt de l'immunohistochimie et apport de la biopsie.
  • Most renal tumors of the adult are carcinomas.
  • We report the case of a 45 year-old woman presenting with renal tumor.
  • A biopsy of the mass showed a metanephric adenoma.
  • Here we develop the interest of immunohistochemistry for differential diagnosis of metanephric adenoma and other "basophilic small cell tumors" of the kidney.
  • We also put the stress on the growing role of biopsy of renal tumor allowing optimal treatment.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18185471.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


39. Toxicology and carcinogenesis studies of benzophenone (CAS No. 119-61-9) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser; 2006 Feb;(533):1-264
Hazardous Substances Data Bank. BENZOPHENONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was a positive trend in the incidences of renal tubule adenoma in males, and the incidences in 625 and 1,250 ppm males exceeded the historical control range for all routes; these neoplasms were accompanied by significantly increased incidences of renal tubule hyperplasia.
  • Due to these findings, additional kidney sections were evaluated; results indicated additional renal tubule adenomas in all groups of males and renal tubule hyperplasia in all groups of males and females.
  • Increased incidences of mononuclear cell leukemia in all exposed groups of females exceeded the historical control range from feed studies, and the incidence in 625 ppm females was significantly greater than that in the controls.
  • Male rats exposed to 312 or 625 ppm had significantly increased incidences of mononuclear cell leukemia.
  • In male mice, there were significantly increased incidences of hepatocellular adenoma in the 625 and 1,250 ppm groups, and these incidences exceeded the historical control range.
  • In female mice, the incidences of hepatocellular adenoma in the 625 and 1,250 ppm groups were higher than expected after adjusting for the lower body weights in these groups.
  • The incidences of kidney nephropathy and mineralization in exposed groups of females and the severity of nephropathy in exposed groups of males were significantly increased.
  • CONCLUSIONS: Under the conditions of these 2-year studies, there was some evidence of carcinogenic activity of benzophenone in male F344/N rats based on increased incidences of renal tubule adenoma; mononuclear cell leukemia in male F344/N rats may have been related to benzophenone exposure.
  • There was equivocal evidence of carcinogenic activity of benzophenone in female F344/N rats based on the marginally increased incidences of mononuclear cell leukemia and histiocytic sarcoma.
  • There was some evidence of carcinogenic activity of benzophenone in male B6C3F1 mice based on increased incidences of hepatocellular neoplasms, primarily adenoma.
  • There was some evidence of carcinogenic activity of benzophenone in female B6C3F1 mice based on increased incidences of histiocytic sarcoma; the incidences of hepatocellular adenoma in female B6C3F1 mice may have been related to benzophenone exposure.
  • Administration of benzophenone in feed resulted in increased incidences and/or severities of nonneoplastic lesions in the kidney and liver of male and female rats and in the liver, kidney, nose, and spleen of male and female mice.
  • [MeSH-minor] Animals. Body Weight / drug effects. Carcinogenicity Tests. Dose-Response Relationship, Drug. Female. Histiocytic Disorders, Malignant / chemically induced. Histiocytic Disorders, Malignant / pathology. Kidney Neoplasms / chemically induced. Kidney Neoplasms / pathology. Leukemia / chemically induced. Leukemia / pathology. Liver Neoplasms / chemically induced. Liver Neoplasms / pathology. Longevity / drug effects. Male. Mice. Mice, Inbred C57BL. Mutagenicity Tests. Rats. Rats, Inbred F344. Sarcoma / chemically induced. Sarcoma / pathology. Toxicity Tests, Chronic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16741556.001).
  • [ISSN] 0888-8051
  • [Journal-full-title] National Toxicology Program technical report series
  • [ISO-abbreviation] Natl Toxicol Program Tech Rep Ser
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Benzophenones; 0 / Photosensitizing Agents; 701M4TTV9O / benzophenone
  •  go-up   go-down


40. Morelli L, Pusiol T, Piscioli I, Larosa M, Pozzoli GL, Monica B: Concurrent occurrence of three primary neoplasms with different hystotype in the same kidney, associated with an adenoma of the omolateral adrenal gland: first case report. Int J Urol; 2006 Sep;13(9):1236-9
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Concurrent occurrence of three primary neoplasms with different hystotype in the same kidney, associated with an adenoma of the omolateral adrenal gland: first case report.
  • We present an unusual case of concurrent occurrence of three synchronous primary tumors in the same kidney (oncocytoma, chromophobe renal cell carcinoma, angiomyolipoma) associated to an adenoma of the omolateral adrenal gland in a patient with no evident clinical symptoms.
  • The immunohistochemistry showed a positivity for KIT in oncocytoma and chromophobe cell carcinoma, and a weak positivity in the angiomyolipoma, only in the cells positive for HMB-45.
  • [MeSH-major] Adenoma / pathology. Adenoma, Oxyphilic / pathology. Adrenal Gland Neoplasms / pathology. Angiomyolipoma / pathology. Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology. Neoplasms, Multiple Primary / pathology

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16984560.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


41. Loeser A, Katzenberger T, Spahn M, Gerharz EW, Riedmiller H: Metanephric adenoma in a two-year-old child. Urol Int; 2009;83(1):119-21
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma in a two-year-old child.
  • Metanephric adenomas in children are very rare.
  • We present the case of a 2-year-old girl with a mass of the left kidney.
  • Histopathologic examination revealed a metanephric adenoma.
  • [MeSH-major] Adenoma / diagnosis. Kidney Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 S. Karger AG, Basel.
  • (PMID = 19641372.001).
  • [ISSN] 1423-0399
  • [Journal-full-title] Urologia internationalis
  • [ISO-abbreviation] Urol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


42. Yaqoob N, Paryani JP, Kayani N, Rafique MZ, Biyabani R: Metanephric adenoma: a rare benign renal tumour. J Pak Med Assoc; 2005 Nov;55(11):511-2
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma: a rare benign renal tumour.
  • Metanephric adenoma is a rare benign renal tumour.
  • Nephrectomy was done and histopathology was consistent with the diagnosis of metanephric adenoma.
  • This novel renal mass has been reported to have benign clinical course despite its symptomatic presentation and large tumour size.
  • So far, a uniformly benign clinical course has been associated with Metanephric adenoma, but given its relatively recent identification and rarity and the lack of clinical, radiographic, or cytologic means to establish a definite diagnosis, Metanephric adenoma remains primarily a pathologic diagnosis.
  • [MeSH-major] Adenoma / diagnosis. Kidney Neoplasms / diagnosis. Nephrectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16304876.001).
  • [ISSN] 0030-9982
  • [Journal-full-title] JPMA. The Journal of the Pakistan Medical Association
  • [ISO-abbreviation] J Pak Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


43. National Toxicology Program: Toxicology and carcinogenesis studies of cumene (CAS No. 98-82-8) in F344/N rats and B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser; 2009 Feb;(542):1-200
Hazardous Substances Data Bank. Isopropylbenzene .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenomas of the respiratory epithelium of the nose were observed in male and female rats, and male rats had increased incidences of renal tubule adenoma or carcinoma (combined) and interstitial cell adenoma of the testis.
  • Adenomas and carcinomas of the lung were markedly increased in male and female mice exposed to cumene.
  • The rate of liver neoplasms was also increased in exposed female mice, and a few hemangiosarcomas of the spleen and follicular cell adenomas of the thyroid gland were seen in male mice exposed to the highest concentration of cumene.
  • CONCLUSIONS: We conclude that the increased occurrences of adenomas of the epithelium of the nose in male and female rats, of renal tubule adenoma or carcinoma (combined), of adenomas and carcinomas of the lung in male and female mice, and of liver neoplasms in female mice were caused by exposure to cumene.
  • The occurrence of interstitial cell adenoma of the testis in male rats and hemangiosarcomas of the spleen and follicular cell adenomas of the thyroid gland in male mice may also have been associated with exposure to cumene.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19340095.001).
  • [ISSN] 0888-8051
  • [Journal-full-title] National Toxicology Program technical report series
  • [ISO-abbreviation] Natl Toxicol Program Tech Rep Ser
  • [Language] eng
  • [Publication-type] Journal Article; Technical Report
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Benzene Derivatives; 8Q54S3XE7K / cumene
  •  go-up   go-down


44. Hes O, Síma R, Nemcová J, Hora M, Bulimbasic S, Kazakov DV, Urge T, Reischig T, Dvorák M, Michal M: End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue. Virchows Arch; 2008 Oct;453(4):313-9
MedlinePlus Health Information. consumer health - Kidney Failure.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.
  • The aim of this study was to determine the copy number changes of chromosomes 7, 17, 3p, and Y in a non-neoplastic tubular epithelium in end-stage kidney disease (ESKD).
  • Non-neoplastic kidney tissue in these cases was examined separately.
  • Tissues containing papillary adenomas (PA), clear (CRCC) and papillary renal cell carcinomas (PRCC), and myxoid liposarcoma (LPS) were examined using the same probes and compared with non-neoplastic tissue.
  • Tubular changes in the kidney parenchyma were classified into three types:.
  • (2) Several tubules were hyperplastic, i.e., tubules with undifferentiated large epithelial cells, in which it was impossible to establish the specific type of a renal tubulus;.
  • Fluorescence in situ hybridization on tissues containing papillary adenomas, renal cell carcinomas, and liposarcoma revealed expected results, i.e., trisomy of chromosomes 7 and 17 in all PAs and PRCC.
  • We suggest that chromosomal changes typical of the papillary renal cell lesions, i.e., trisomies of chromosomes 7 and 17, are very frequent in non-neoplastic parenchyma of the end-stage kidney, and they have a tendency to a multifocal occurrence.
  • [MeSH-major] Chromosomes, Human, Pair 17 / genetics. Chromosomes, Human, Pair 7 / genetics. Chromosomes, Human, Y / genetics. Kidney / ultrastructure. Kidney Failure, Chronic / genetics
  • [MeSH-minor] Adenoma / genetics. Adult. Aged. Carcinoma, Renal Cell / genetics. Female. Humans. In Situ Hybridization, Fluorescence. Kidney Tubules / pathology. Liposarcoma, Myxoid / genetics. Male. Middle Aged. Trisomy / genetics. Trisomy / pathology

  • Genetic Alliance. consumer health - Kidney Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2006 Feb;30(2):141-53 [16434887.001]
  • [Cites] J Pathol. 1997 Oct;183(2):131-3 [9390023.001]
  • [Cites] World J Urol. 2004 Jun;22(2):120-3 [14689223.001]
  • [Cites] Cancer Genet Cytogenet. 1996 Jul 1;89(1):65-8 [8689614.001]
  • [Cites] Mod Pathol. 1999 Mar;12(3):301-9 [10102616.001]
  • [Cites] J Pathol. 1998 Apr;184(4):424-9 [9664910.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9744-8 [1409692.001]
  • [Cites] Hum Genet. 1995 Feb;95(2):149-56 [7860060.001]
  • [Cites] Mod Pathol. 2003 Oct;16(10):1053-9 [14559990.001]
  • [Cites] J Urol. 2002 Dec;168(6):2632-6 [12441999.001]
  • [Cites] J Pathol. 1999 Feb;187(3):308-12 [10398084.001]
  • [Cites] Genes Chromosomes Cancer. 1991 Jul;3(4):249-55 [1958590.001]
  • [Cites] Am J Surg Pathol. 2005 Apr;29(4):443-51 [15767796.001]
  • [Cites] Cytogenet Cell Genet. 1995;69(1-2):90-6 [7835096.001]
  • [Cites] Transplantation. 1999 Aug 15;68(3):385-90 [10459542.001]
  • [Cites] J Urol. 2006 Jun;175(6):2018-20; discussion 2021 [16697788.001]
  • [Cites] J Am Soc Nephrol. 1996 Nov;7(11):2461-8 [8959640.001]
  • [Cites] Am J Surg Pathol. 1994 Nov;18(11):1117-24 [7943532.001]
  • [Cites] J Urol. 2005 Aug;174(2):731-5 [16006966.001]
  • [Cites] Urology. 1999 Apr;53(4):684-9 [10197841.001]
  • (PMID = 18795325.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


45. Lerut E, Roskams T, Joniau S, Oyen R, Achten R, Van Poppel H, Debiec-Rychter M: Metanephric adenoma during pregnancy: clinical presentation, histology, and cytogenetics. Hum Pathol; 2006 Sep;37(9):1227-32
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma during pregnancy: clinical presentation, histology, and cytogenetics.
  • Metanephric adenoma is a rare benign tumor of the kidney.
  • It is considered to be derived from embryonic renal tissue and to be the benign counterpart of the Wilms tumor.
  • At renal ultrasonography and magnetic resonance imaging, a hemorrhagic tumor of 10 cm in diameter originating from the right kidney was seen.
  • Based on the imaging findings, the diagnosis of a cystic renal cell carcinoma with recent hemorrhage was suggested, and a radical nephrectomy was performed.
  • Pathologic examination concluded to a metanephric adenoma.
  • To our knowledge, this is the first report on these chromosomal abnormalities in metanephric adenoma.
  • [MeSH-major] Adenoma / genetics. Adenoma / pathology. Kidney Neoplasms / genetics. Kidney Neoplasms / pathology. Pregnancy Complications / genetics. Pregnancy Complications / pathology
  • [MeSH-minor] Adult. Carcinoma, Renal Cell / pathology. Chromosome Aberrations. Diagnosis, Differential. Female. Humans. In Situ Hybridization, Fluorescence. Kidney / embryology. Kidney / pathology. Magnetic Resonance Imaging. Nephrectomy. Pregnancy. Ultrasonography. Wilms Tumor / pathology


46. Herlitz LC, Tong GX, Hamele-Bena D, Greenebaum E: Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining. Diagn Cytopathol; 2008 Jan;36(1):47-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining.
  • However, the cytologic features of nonneoplastic lesions of the lower urinary tract, including nephrogenic adenoma, are nonspecific and may cause false positive diagnosis.
  • Recent evidence has demonstrated that nephrogenic adenoma is a true "nephrogenic" lesion derived from the exfoliated and implanted renal tubular cells in the urinary tract.
  • This has promoted the use of immunostaining of renal transcription factor PAX2 in tissue biopsies to differentiate nephrogenic adenoma from the common malignant tumors of the lower urinary tract.
  • We report here that PAX2 immunostaining can also be used in urine cytology specimen to identify nephrogenic adenoma.
  • Combination of PAX2 immunostaining and cytologic analysis may increase the accuracy in identifying this benign lesion in urine cytology specimen and therefore reduce unnecessary repeat cystoscopy and biopsy procedures.
  • This may be a cost effective follow- up method for patients with an established diagnosis of nephrogenic adenoma.
  • [MeSH-major] Adenoma / diagnosis. PAX2 Transcription Factor / metabolism. Urinary Bladder Neoplasms / diagnosis. Urine / cytology
  • [MeSH-minor] Aged. Female. Humans. Immunohistochemistry. Kidney Tubules / metabolism. Kidney Tubules / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Urine and Urination.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18064687.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / PAX2 Transcription Factor; 0 / PAX2 protein, human
  •  go-up   go-down


47. Wolf A, Willenberg HS, Cupisti K, Schott M, Geddert H, Raffel A, Bornstein SR, Scherbaum WA, Knoefel WT: Adrenal pheochromocytoma with contralateral cortisol-producing adrenal adenoma: diagnostic and therapeutic management. Horm Metab Res; 2005 Jun;37(6):391-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal pheochromocytoma with contralateral cortisol-producing adrenal adenoma: diagnostic and therapeutic management.
  • To contribute to the studies of systemic interactions between these tissues, we studied a 52-year-old female patient with a pheochromocytoma and a contralateral cortisol-producing adenoma.
  • Due to a misunderstanding, she presented to her family doctor to have an inherited kidney disease ruled out.
  • Laboratory work-up, selective adrenal venous sampling and magnetic resonance imaging studies established the diagnosis of a pheochromocytoma in the right-hand adrenal gland and a cortisol-producing adenoma on the left.
  • Although presence of bilateral adrenal adenomas or bilateral adrenal pheochromocytomas in certain inherited disorders are possible, this rare case of an adrenal pheochromocytoma combined with a contralateral cortisol-producing adrenal adenoma may further underline the wide range of complex interactions between the two endocrine systems.
  • [MeSH-major] Adrenal Cortex Neoplasms / radiography. Adrenocortical Adenoma / radiography. Pheochromocytoma / radiography

  • Genetic Alliance. consumer health - Pheochromocytoma.
  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16001333.001).
  • [ISSN] 0018-5043
  • [Journal-full-title] Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme
  • [ISO-abbreviation] Horm. Metab. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


48. Ebbing J, Blind C, Stein H, Miller K, Loddenkemper C: Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to date. Rare Tumors; 2009;1(2):e54

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to date.
  • Pleomorphic adenomas (benign mixed tumors) are the most common tumors of glandular origin in the head and neck and are one of the few benign neoplasms that can undergo malignant transformation.(1) Mixed tumors that are seemingly benign at the microscopic level but metastasize have been termed metastasizing mixed tumors (MZMTs).
  • The entity of metastasizing benign mixed tumors has been reported since the early 1940s, with up to approximately 50 cases described in the literature to date.
  • Despite their bland morphologic appearance, MZMTs have been associated with an overall mortality rate of about 20-40%.
  • We report the case of a MZMT of the kidney almost 30 years after lateral parotidectomy owing to the same tumor entity.
  • For benign mixed tumors, we are unaware of more than two other cases of metastasis to the kidney that have been published, whereas metastases to the bone, lung, and lymph nodes are more common.
  • This case report provides information about the rare event of metastatic disease to the kidney and points out therapeutic strategies.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21139933.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2994456
  • [Keywords] NOTNLM ; carcinoma ex-mixed tumor / kidney metastasis / kidney tumor. / metastasizing mixed tumor / metastasizing pleomorphic adenoma
  •  go-up   go-down


49. Chiu YC, Chang YH, Pan CC, Chen KK: Nephrogenic adenoma arising in a renal cortical cyst. J Chin Med Assoc; 2005 Sep;68(9):444-6
MedlinePlus Health Information. consumer health - Kidney Cysts.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nephrogenic adenoma arising in a renal cortical cyst.
  • Nephrogenic adenoma is an unusual lesion of the urinary tract first described by Davis in 1949 as a hamartoma.
  • In 1950, Friedman and Kuhlenbeck subsequently characterized the lesion in more detail and named it nephrogenic adenoma.
  • It appears to be a metaplastic response of the urothelium elicited by trauma and chronic irritation and is considered to be benign.
  • A MEDLINE search of the literature from 1960 to the present revealed no previous documentation of a nephrogenic adenoma arising from a renal cortical cyst.
  • Herein, we present such a case arising in a renal cortical cyst.
  • [MeSH-major] Adenoma / pathology. Kidney Diseases, Cystic / pathology. Kidney Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16187604.001).
  • [ISSN] 1726-4901
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


50. Kim MS, Kim SK, Kim SI, Kim YS, Jeong HJ: Ureteral nephrogenic adenoma in a renal allograft patient. Int J Urol; 2008 Feb;15(2):178-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ureteral nephrogenic adenoma in a renal allograft patient.
  • A 56-year-old male who had renal transplants at the age of 34 and 49 years, presented with painless gross hematuria six years after the second renal transplantation.
  • An abdominal computed tomography scan revealed diffuse wall thickening of the distal ureter of the failed first allograft and a bulging lesion about 1.2 cm in size on the lower pole of the right native kidney.
  • Both lesions were suspected for tumors, but they showed a ureteral nephrogenic adenoma and a renal hemorrhagic simple cyst.
  • [MeSH-major] Adenoma / diagnosis. Cysts / diagnosis. Hematuria / etiology. Kidney Diseases / diagnosis. Ureteral Neoplasms / diagnosis
  • [MeSH-minor] Humans. Kidney Transplantation. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Kidney Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18269460.001).
  • [ISSN] 1442-2042
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


51. Chiou TT, Chiang PH, Fuh M, Liu RT, Lee WC, Lee WC, Ng HY, Tsai YC, Chuang FR, Huang CC, Lee CT: Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma. Tohoku J Exp Med; 2009 May;218(1):17-24
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma.
  • Primary aldosteronism is an important cause of secondary hypertension, because it is potentially curable, especially in case of unilateral aldosterone-producing adrenal adenoma (APA).
  • However, the information is limited concerning the cardiovascular and renal outcomes in this patient population.
  • We studied 52 patients with APA in order to determine the pre-operative and post-operative factors predicting cardiovascular and renal outcomes.
  • Patients whose renal function worsened after adrenalectomy had significantly higher pre-operative plasma active renin levels.
  • Thus, in patients with APA, the presence of LVH is correlated with impaired renal function (lower eGFR).
  • In conclusion, pre-operative BP and post-operative plasma aldosterone are important in predicting post-adrenalectomy hypertension, and a lower pre-operative plasma renin predicts the improvement in renal function after adrenalectomy.
  • [MeSH-major] Adrenal Cortex Neoplasms. Adrenalectomy. Adrenocortical Adenoma. Aldosterone / blood. Cardiovascular System / metabolism. Hypertension. Kidney

  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19398869.001).
  • [ISSN] 1349-3329
  • [Journal-full-title] The Tohoku journal of experimental medicine
  • [ISO-abbreviation] Tohoku J. Exp. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone
  •  go-up   go-down


52. Yoshioka K, Miyakawa A, Ohno Y, Namiki K, Horiguchi Y, Murai M, Mukai M, Tachibana M: Production of erythropoietin and multiple cytokines by metanephric adenoma results in erythrocytosis. Pathol Int; 2007 Aug;57(8):529-36
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Production of erythropoietin and multiple cytokines by metanephric adenoma results in erythrocytosis.
  • This is the first report of direct evidence that metanephric adenoma cells produce erythropoietin and other types of cytokines, which may be the cause of the high incidence of erythrocytosis in patients with this tumor.
  • The purpose of the study was to establish a metanephric adenoma cell line in vitro from nephrectomized tumor tissue in order to investigate the ability of metanephric adenoma cells to produce erythropoietin and other types of cytokines.
  • The tumor tissue was obtained from a 16-year-old boy who had developed metanephric adenoma with erythrocytosis and was served for cell culture.
  • Significantly high concentrations of erythropoietin, granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte-colony-stimulating factor (G-CSF), interleukin-6 (IL-6), and IL-8 were detected in the cell culture supernatant.
  • [MeSH-major] Adenoma / metabolism. Cytokines / metabolism. Erythropoietin / metabolism. Kidney Neoplasms / metabolism. Polycythemia / metabolism
  • [MeSH-minor] Adolescent. Biomarkers, Tumor / metabolism. Cell Nucleus / ultrastructure. Gene Expression. Humans. Male. Nephrectomy. RNA, Messenger / metabolism. Treatment Outcome. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17610479.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cytokines; 0 / RNA, Messenger; 11096-26-7 / Erythropoietin
  •  go-up   go-down


53. Touloupidis S, Thamnopoulos C, Fatles G, Papathanasiou A, Giannakopoulos S, Rombis V: Metanephric adenoma. A case report and a review of the literature. Arch Ital Urol Androl; 2006 Jun;78(2):79-81
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma. A case report and a review of the literature.
  • Metanephric adenoma is an exceptionally infrequent tumor so far considered benign in nature.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16929611.001).
  • [ISSN] 1124-3562
  • [Journal-full-title] Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • [ISO-abbreviation] Arch Ital Urol Androl
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


54. Rakheja D, Lian F, Tomlinson GE, Ewalt DH, Schultz RA, Margraf LR: Renal metanephric adenoma with previously unreported cytogenetic abnormalities: case report and review of the literature. Pediatr Dev Pathol; 2005 Mar-Apr;8(2):218-23
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal metanephric adenoma with previously unreported cytogenetic abnormalities: case report and review of the literature.
  • We report a case of a renal metanephric adenoma in a 10-year-old boy, in which cytogenetic analysis showed a balanced translocation, t(9;15)(p24;q24) and a balanced paracentric inversion of chromosome 12, inv(12)(q13q15).
  • Published cytogenetic data for metanephric adenomas are limited, and this is the first report of these cytogenetic abnormalities.
  • The involvement of the chromosome region 9p24 is particularly interesting because of the recent identification of a tumor suppressor gene, KANK (kidney ankyrin repeat-containing protein), at this locus.
  • [MeSH-major] Adenoma / genetics. Chromosome Inversion / genetics. Chromosomes, Human, 6-12 and X / genetics. Chromosomes, Human, Pair 15 / genetics. Kidney Neoplasms / genetics. Translocation, Genetic / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15747102.001).
  • [ISSN] 1093-5266
  • [Journal-full-title] Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
  • [ISO-abbreviation] Pediatr. Dev. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


55. Liu H, Yamaki T, Oka S, Koyanagi I, Houkin K: Metastatic renal cell carcinoma mimicking pituitary adenoma: case report. Neurol Med Chir (Tokyo); 2005 Aug;45(8):418-22
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic renal cell carcinoma mimicking pituitary adenoma: case report.
  • A 54-year-old man, with a past history of renal cell carcinoma, presented with bitemporal visual field defect, hyponatremia, and diabetes insipidus.
  • The initial radiological impression was pituitary adenoma.
  • Histological examination revealed metastatic renal cell carcinoma.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Neoplasm, Residual / secondary. Pituitary Gland / pathology. Pituitary Neoplasms / secondary. Prolactinoma / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Humans. Hypopituitarism / etiology. Hypopituitarism / pathology. Magnetic Resonance Imaging. Male. Middle Aged. Neurosurgical Procedures. Radiotherapy. Sella Turcica / pathology. Sella Turcica / radiography. Sella Turcica / surgery. Treatment Outcome


56. Paner GP, Turk TM, Clark JI, Lindgren V, Picken MM: Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes. Arch Pathol Lab Med; 2005 Oct;129(10):1317-21
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes.
  • However, rarely, inconsequential passive transport of benign neoplastic cells to the lymph node can occur and may cause confusion as to the nature of the neoplasm (ie, malignant vs benign).
  • We describe a 10-cm right renal metanephric adenoma incidentally discovered in a 30-year-old woman during cesarean section for a triplet pregnancy.
  • Subsequent nephrectomy following an equivocal needle biopsy diagnosis showed histologic features classic for metanephric adenoma, including the lack of cytologic atypia and mitoses.
  • The tumor proliferation index with Ki-67 was only 3% to 5% and the proliferating cell nuclear antigen index was 0%.
  • We postulate that the lymph node inclusions found in this case represent passive transport of neoplastic cells to the lymph node following manipulation of the renal mass.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology. Lymph Nodes / pathology. Neoplasm Seeding
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Carcinoma, Renal Cell / diagnosis. Carcinoma, Renal Cell / secondary. Cytogenetic Analysis. Diagnosis, Differential. Female. Humans. Kidney / pathology. Neoplasm Metastasis / diagnosis. Pregnancy. Wilms Tumor / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16196523.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


57. Lamprecht G, Hsieh CJ, Lissner S, Nold L, Heil A, Gaco V, Schäfer J, Turner JR, Gregor M: Intestinal anion exchanger down-regulated in adenoma (DRA) is inhibited by intracellular calcium. J Biol Chem; 2009 Jul 17;284(29):19744-53
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intestinal anion exchanger down-regulated in adenoma (DRA) is inhibited by intracellular calcium.
  • The Na/H exchanger 3 (NHE3) and the Cl/HCO(3) exchanger down-regulated in adenoma (DRA) together facilitate intestinal electroneutral NaCl absorption.
  • Elevated Ca(2+)(i) inhibits NHE3 through mechanisms involving the PDZ domain proteins NHE3 kinase A regulatory protein (E3KARP) or PDZ kidney 1 (PDZK1).
  • Wild type DRA and a mutant lacking the PDZ interaction motif (DRA-ETKFminus) were expressed constitutively in human embryonic kidney (HEK) and inducibly in Caco-2/BBE cells.
  • [MeSH-minor] Binding Sites / genetics. Caco-2 Cells. Calcimycin / analogs & derivatives. Calcimycin / pharmacology. Cell Line. Chloride-Bicarbonate Antiporters. Cystic Fibrosis Transmembrane Conductance Regulator / genetics. Cystic Fibrosis Transmembrane Conductance Regulator / metabolism. Gene Expression / drug effects. Green Fluorescent Proteins / genetics. Green Fluorescent Proteins / metabolism. Humans. Hydrogen-Ion Concentration. Immunoblotting. Intestines / metabolism. Intracellular Space / metabolism. Ionophores / pharmacology. Mutation. PDZ Domains / genetics. Phosphoproteins / genetics. Phosphoproteins / metabolism. Protein Binding. Recombinant Fusion Proteins / genetics. Recombinant Fusion Proteins / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Sodium-Hydrogen Antiporter / genetics. Sodium-Hydrogen Antiporter / metabolism. Transfection. Uridine Triphosphate / pharmacology

  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 1995 Jun 9;270(23):13716-25 [7775426.001]
  • [Cites] Am J Physiol Cell Physiol. 2009 Jun;296(6):C1279-90 [19321737.001]
  • [Cites] J Biol Chem. 1998 Apr 10;273(15):8790-8 [9535857.001]
  • [Cites] Nat Genet. 1998 Jul;19(3):282-5 [9662405.001]
  • [Cites] Br J Pharmacol. 2000 Dec;131(8):1651-8 [11139443.001]
  • [Cites] J Biol Chem. 2001 Jul 20;276(29):26906-15 [11328806.001]
  • [Cites] Gastroenterology. 2002 Mar;122(3):709-24 [11875004.001]
  • [Cites] J Biol Chem. 1998 Oct 2;273(40):25856-63 [9748260.001]
  • [Cites] Am J Physiol. 1999 Jan;276(1 Pt 1):G185-92 [9886994.001]
  • [Cites] J Biol Chem. 1999 Aug 6;274(32):22855-61 [10428871.001]
  • [Cites] Pflugers Arch. 2005 Feb;449(5):479-90 [15480750.001]
  • [Cites] Biochemistry. 2005 Mar 22;44(11):4477-87 [15766278.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 31;102(22):8042-7 [15901899.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 2005 Jun;371(6):466-72 [16025270.001]
  • [Cites] J Biol Chem. 2002 Jun 21;277(25):22925-33 [11956211.001]
  • [Cites] J Biol Chem. 2002 Jun 28;277(26):23714-24 [11948184.001]
  • [Cites] Cancer Res. 2002 Sep 1;62(17):5083-8 [12208765.001]
  • [Cites] Biochemistry. 2002 Oct 15;41(41):12336-42 [12369822.001]
  • [Cites] EMBO J. 2002 Nov 1;21(21):5662-72 [12411484.001]
  • [Cites] J Clin Invest. 2002 Dec;110(11):1651-8 [12464670.001]
  • [Cites] Am J Physiol Renal Physiol. 2003 Mar;284(3):F419-32 [12556361.001]
  • [Cites] J Clin Invest. 2003 Apr;111(7):931-43 [12671039.001]
  • [Cites] J Physiol. 2003 May 15;549(Pt 1):3-19 [12651923.001]
  • [Cites] Am J Physiol Cell Physiol. 2003 Dec;285(6):C1527-36 [12954600.001]
  • [Cites] Pflugers Arch. 2004 Feb;447(5):710-21 [12759755.001]
  • [Cites] J Physiol. 2004 Mar 1;555(Pt 2):311-21 [14694149.001]
  • [Cites] Nat Cell Biol. 2004 Apr;6(4):343-50 [15048129.001]
  • [Cites] J Physiol. 2004 May 1;556(Pt 3):791-804 [14978207.001]
  • [Cites] J Biol Chem. 2004 Oct 29;279(44):45942-50 [15304510.001]
  • [Cites] Am J Physiol. 1988 Dec;255(6 Pt 1):C844-56 [2849306.001]
  • [Cites] J Clin Invest. 1991 Sep;88(3):855-63 [1885773.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13331-6 [16141316.001]
  • [Cites] J Gen Physiol. 2006 May;127(5):511-24 [16606687.001]
  • [Cites] J Cell Sci. 2006 May 15;119(Pt 10):2095-106 [16638813.001]
  • [Cites] Pflugers Arch. 2006 Jun;452(3):307-15 [16715296.001]
  • [Cites] J Clin Invest. 2006 Oct;116(10):2682-94 [17016558.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2006 Nov;291(5):G766-77 [16798722.001]
  • [Cites] J Biol Chem. 2006 Dec 8;281(49):37962-71 [17001077.001]
  • [Cites] J Physiol. 2007 Jun 15;581(Pt 3):1235-46 [17395628.001]
  • [Cites] Physiol Rev. 2007 Jul;87(3):825-72 [17615390.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G202-10 [19056765.001]
  • [Cites] Gastroenterology. 2009 Mar;136(3):893-901 [19121635.001]
  • [Cites] Am J Physiol. 1997 Jun;272(6 Pt 1):C1862-70 [9227415.001]
  • (PMID = 19447883.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antiporters; 0 / CFTR protein, human; 0 / Chloride-Bicarbonate Antiporters; 0 / Ionophores; 0 / Membrane Proteins; 0 / PDZK1IP1 protein, human; 0 / Phosphoproteins; 0 / Recombinant Fusion Proteins; 0 / SLC26A3 protein, human; 0 / Sodium-Hydrogen Antiporter; 0 / sodium-hydrogen exchanger 3; 0 / sodium-hydrogen exchanger regulatory factor; 126880-72-6 / Cystic Fibrosis Transmembrane Conductance Regulator; 147336-22-9 / Green Fluorescent Proteins; 37H9VM9WZL / Calcimycin; 76455-48-6 / 4-bromo-A-23187; SY7Q814VUP / Calcium; UT0S826Z60 / Uridine Triphosphate
  • [Other-IDs] NLM/ PMC2740598
  •  go-up   go-down


58. Barmeyer C, Ye JH, Sidani S, Geibel J, Binder HJ, Rajendran VM: Characteristics of rat downregulated in adenoma (rDRA) expressed in HEK 293 cells. Pflugers Arch; 2007 Jun;454(3):441-50
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characteristics of rat downregulated in adenoma (rDRA) expressed in HEK 293 cells.
  • These studies proposed that anion exchanger (AE)-1 isoform encodes the former as both apical membrane DIDS-sensitive CL(-)-HCO(3)(-) exchange, and AE1 specific mRNA are present only in surface cells and are downregulated in Na-depleted rats, whereas downregulated in adenoma (DRA) encodes the latter as both DIDS-resistant Cl(-)-OH(-) exchange, and DRA-specific proteins are present in apical membranes of both surface and crypt cells and are not altered in Na(+)-depleted rats.
  • Studies were, therefore, initiated to identify the function of rat DRA (rDRA) in vitro. rDRA cDNA isolated from rat distal colon encodes a 757-amino-acid protein which has 96 and 81% homology with mDRA and hDRA, respectively. rDRA-specific mRNA expression was detectable only in specific segments of the digestive tract (duodenum, ileum, cecum, proximal colon, and distal colon) but not in the stomach, jejunum, or in the kidney, brain, heart, and lung.
  • [MeSH-minor] 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / pharmacology. Amino Acid Sequence. Animals. Base Sequence. Bicarbonates / metabolism. Bicarbonates / pharmacology. Cell Line. Chlorides / metabolism. Chlorides / pharmacology. Cloning, Molecular. Colon / metabolism. DNA Primers / genetics. Fatty Acids, Volatile / pharmacology. Humans. Hydrogen-Ion Concentration. Ion Transport / drug effects. Molecular Sequence Data. Rats. Recombinant Proteins / genetics. Recombinant Proteins / metabolism. Sequence Homology, Amino Acid. Transfection

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pflugers Arch. 2005 Feb;449(5):479-90 [15480750.001]
  • [Cites] J Clin Invest. 1975 Aug;56(2):302-10 [1150872.001]
  • [Cites] Gastroenterology. 1987 Sep;93(3):449-55 [3609655.001]
  • [Cites] J Membr Biol. 1994 Jul;141(1):51-8 [7966245.001]
  • [Cites] J Physiol. 2003 May 15;549(Pt 1):3-19 [12651923.001]
  • [Cites] Arch Dis Child. 1977 Apr;52(4):255-67 [324405.001]
  • [Cites] Am J Physiol. 1973 Feb;224(2):328-37 [4346845.001]
  • [Cites] Genome Res. 1996 Mar;6(3):202-10 [8963897.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2002 Sep;283(3):G626-33 [12181176.001]
  • [Cites] Am J Physiol. 1979 Jan;236(1):F1-8 [219705.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 May 1;90(9):4166-70 [7683425.001]
  • [Cites] Am J Physiol. 1990 Jun;258(6 Pt 1):G825-32 [2163204.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G931-42 [11052990.001]
  • [Cites] Nat Cell Biol. 2004 Apr;6(4):343-50 [15048129.001]
  • [Cites] J Biol Chem. 1995 May 19;270(20):11897-902 [7744840.001]
  • [Cites] Am J Physiol. 1993 May;264(5 Pt 1):G874-9 [8498514.001]
  • [Cites] Am J Physiol. 1999 Jan;276(1 Pt 1):G132-7 [9886988.001]
  • [Cites] J Clin Invest. 1986 Jan;77(1):170-5 [3003149.001]
  • [Cites] Am J Physiol. 1974 May;226(5):1131-41 [4363363.001]
  • [Cites] Am J Physiol. 1990 Feb;258(2 Pt 1):G261-7 [2305893.001]
  • [Cites] Nat Genet. 1996 Nov;14(3):316-9 [8896562.001]
  • [Cites] Am J Physiol Cell Physiol. 2005 Apr;288(4):C957-65 [15574486.001]
  • [Cites] Cancer Res. 2002 Sep 1;62(17):5083-8 [12208765.001]
  • [Cites] Am J Physiol. 1990 Jul;259(1 Pt 1):C35-40 [2164783.001]
  • [Cites] J Membr Biol. 1985;88(2):199-204 [3005584.001]
  • [Cites] Gastroenterology. 2002 Mar;122(3):709-24 [11875004.001]
  • [Cites] Clin Gastroenterol. 1986 Jul;15(3):583-602 [3527496.001]
  • [Cites] Am J Hum Genet. 1995 Jul;57(1):95-102 [7611301.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2002 Mar;282(3):G573-9 [11842009.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2000 Oct;279(4):G775-80 [11005765.001]
  • [Cites] J Biol Chem. 1999 Aug 6;274(32):22855-61 [10428871.001]
  • [Cites] Anal Biochem. 1987 Apr;162(1):156-9 [2440339.001]
  • [Cites] Am J Physiol. 1999 Jan;276(1 Pt 1):G185-92 [9886994.001]
  • [Cites] Gastroenterology. 1991 Aug;101(2):331-8 [2065907.001]
  • [Cites] Am J Physiol. 1998 Dec;275(6 Pt 1):G1445-53 [9843783.001]
  • (PMID = 17492310.001).
  • [ISSN] 0031-6768
  • [Journal-full-title] Pflugers Archiv : European journal of physiology
  • [ISO-abbreviation] Pflugers Arch.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ AF337809
  • [Grant] United States / NIDDK NIH HHS / DK / DK60069; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antiporters; 0 / Bicarbonates; 0 / Chlorides; 0 / DNA Primers; 0 / Fatty Acids, Volatile; 0 / Recombinant Proteins; 0 / Slc26a3 protein, rat; Q1O6DSW23R / 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
  •  go-up   go-down


59. McNeil JC, Corbett ST, Kuruvilla S, Jones EA: Metanephric adenoma in a five-year-old boy presenting with chyluria: case report and review of literature. Urology; 2008 Sep;72(3):545-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma in a five-year-old boy presenting with chyluria: case report and review of literature.
  • Metanephric adenoma and chyluria are rare entities, especially in the pediatric population of North America.
  • To date, no report of chyluria associated with metanephric adenoma has been published.
  • [MeSH-major] Adenoma / complications. Adenoma / diagnosis. Kidney Neoplasms / complications. Kidney Neoplasms / diagnosis. Urinary Bladder Diseases / complications. Urinary Bladder Diseases / diagnosis. Urology / methods
  • [MeSH-minor] Child. Comorbidity. Humans. Male. Nevus / complications. Nevus / diagnosis. Pediatrics / methods. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18602139.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Jalpota Y, Tewari V, Madan R: Recurrent nephrogenic adenoma of urinary bladder in a renal allograft recipient--a case report. Indian J Pathol Microbiol; 2006 Apr;49(2):261-3
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent nephrogenic adenoma of urinary bladder in a renal allograft recipient--a case report.
  • Nephrogenic adenoma is a rare benign tumour-like lesion within the urothelial mucosa of the urinary tract.
  • It may be an incidental finding in bladder of a patient presenting with haematuria, dysuria and bladder growth after renal allograft transplant.
  • Definite diagnosis is established by histological examination of tumor.
  • Though it attains an extensive spread in bladder mucosa and has a high tendency to recur, the clinical course is benign.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms. Neoplasm Recurrence, Local / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16933732.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


61. Sornmayura P, Siripornpitak S, Leela-udomlipi S, Bunyaratvej S: Hepatocellular adenoma: a case report. J Med Assoc Thai; 2010 Mar;93(3):393-7
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatocellular adenoma: a case report.
  • A case of hepatocellular adenoma (HCA) was described in a 26-year-old woman, who was a potential kidney donor for her father and denied taking the oral contraceptive pill.
  • [MeSH-major] Adenoma, Liver Cell / diagnosis. Liver Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20420118.001).
  • [ISSN] 0125-2208
  • [Journal-full-title] Journal of the Medical Association of Thailand = Chotmaihet thangphaet
  • [ISO-abbreviation] J Med Assoc Thai
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Thailand
  •  go-up   go-down


62. Jain M, Rastogi A, Gupta RK: Atypical metanephric adenoma - a case report and review of literature. Int Urol Nephrol; 2007;39(1):123-7
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Atypical metanephric adenoma - a case report and review of literature.
  • Metanephric adenoma (MA) is a rare renal neoplasm that generally occurs in adults and is considered to have a good prognosis.
  • The authors here report a case of MA with atypical histological features arising in the left kidney of an 18-year-old girl presenting with painless hematuria.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology
  • [MeSH-minor] Adolescent. Female. Humans. Kidney Tubules / pathology. Nephrectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17245551.001).
  • [ISSN] 0301-1623
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Hungary
  • [Number-of-references] 8
  •  go-up   go-down


63. Sawazaki H, Segawa T, Yoshida K, Kawahara T, Inoue T, Soda T, Kamba T, Yoshimura K, Takahashi T, Nakamura E, Nishiyama H, Ito N, Kamoto T, Ogawa O: [Hemorrhagic adrenocortical adenoma with myelolipoma: a case report]. Hinyokika Kiyo; 2006 Oct;52(10):785-8
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Hemorrhagic adrenocortical adenoma with myelolipoma: a case report].
  • We present a case of hemorrhagic adrenocortical adenoma with myelolipoma.
  • Based on abdominal computed tomography, magnetic resonance imaging and blood tests, preoperative diagnosis was a sarcoma of renal capsule origin.
  • En bloc resection of adrenal gland, tumor, and the kidney with lymph node dissection was performed.
  • Histologically, the mass was diagnosed as hemorrhagic adrenocortical adenoma with myelolipomatous foci.
  • [MeSH-major] Adrenal Cortex Neoplasms / complications. Adrenal Gland Neoplasms / etiology. Adrenocortical Adenoma / complications. Myelolipoma / etiology. Neoplasms, Multiple Primary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17131868.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


64. Louiset E, Gobet F, Libé R, Horvath A, Renouf S, Cariou J, Rothenbuhler A, Bertherat J, Clauser E, Grise P, Stratakis CA, Kuhn JM, Lefebvre H: ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma. J Clin Endocrinol Metab; 2010 Jan;95(1):18-24
Hazardous Substances Data Bank. Corticotropin .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.
  • CONTEXT: Bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma are two rare causes of ACTH-independent Cushing's syndrome.
  • OBJECTIVE: The aim of the study was to evaluate a 35-yr-old woman with ACTH-independent hypercortisolism associated with both micronodular adrenal hyperplasia and ectopic pararenal adrenocortical adenoma.
  • The ability of adrenal and adenoma tissues to synthesize cortisol was investigated by immunohistochemistry, quantitative PCR, and/or cell culture studies.
  • MAIN OUTCOME MEASURE: Detection of 17alpha-hydroxylase and 21-hydroxylase immunoreactivities, quantification of CYP11B1 mRNA in adrenal and adenoma tissues, and measurement of cortisol levels in supernatants by radioimmunological assays were the main outcomes.
  • 17alpha-Hydroxylase and 21-hydroxylase immunoreactivities as well as CYP11B1 mRNA were detected in adrenal and adenoma tissues.
  • ACTH and dexamethasone activated cortisol secretion from adenoma cells.
  • CONCLUSION: This case suggests that unknown molecular defects can favor both micronodular adrenal hyperplasia and ectopic adrenocortical adenoma associated with Cushing's syndrome.
  • [MeSH-major] Adrenal Cortex Neoplasms / complications. Adrenal Glands / pathology. Adrenocortical Adenoma / complications. Choristoma / complications. Cushing Syndrome / complications
  • [MeSH-minor] Adrenocorticotropic Hormone / metabolism. Adrenocorticotropic Hormone / pharmacology. Adult. Drug Resistance / genetics. Drug Resistance / physiology. Female. Humans. Hyperplasia / complications. Hyperplasia / genetics. Hyperplasia / radiography. Kidney Diseases / complications. Kidney Diseases / genetics. Kidney Diseases / radiography

  • Genetic Alliance. consumer health - Cushing's Syndrome.
  • MedlinePlus Health Information. consumer health - Cushing's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neuroscience. 1992;47(4):999-1007 [1374544.001]
  • [Cites] Eur J Pediatr. 1986 Aug;145(3):236-8 [3769985.001]
  • [Cites] Ann Intern Med. 1999 Oct 19;131(8):585-91 [10523219.001]
  • [Cites] Horm Res. 2005;64(3):119-31 [16215323.001]
  • [Cites] Mol Cell Endocrinol. 2006 Feb 26;246(1-2):142-6 [16388891.001]
  • [Cites] Nat Genet. 2006 Jul;38(7):794-800 [16767104.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Nov;91(11):4205-14 [16912124.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Nov;91(11):4578-86 [16954157.001]
  • [Cites] Nat Clin Pract Endocrinol Metab. 2007 Nov;3(11):748-57 [17955016.001]
  • [Cites] Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1245-52 [18209862.001]
  • [Cites] N Engl J Med. 2008 Feb 14;358(7):750-2 [18272904.001]
  • [Cites] Clin Cancer Res. 2008 Jun 15;14(12):4016-24 [18559625.001]
  • [Cites] Eur J Hum Genet. 2008 Oct;16(10):1245-53 [18431404.001]
  • [Cites] Nat Clin Pract Endocrinol Metab. 2008 Dec;4(12):695-700 [18941436.001]
  • [Cites] J Clin Endocrinol Metab. 2009 Jul;94(7):2406-13 [19383776.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Jul;86(13):4978-81 [2544885.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Aug;85(8):2903-6 [10946901.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Sep;86(9):4041-6 [11549623.001]
  • [Cites] Am J Hum Genet. 2002 Dec;71(6):1433-42 [12424709.001]
  • [Cites] J Clin Endocrinol Metab. 2003 May;88(5):1994-8 [12727943.001]
  • [Cites] Cancer Res. 2003 Sep 1;63(17):5308-19 [14500362.001]
  • [Cites] Endocr Relat Cancer. 2004 Jun;11(2):265-80 [15163302.001]
  • [Cites] J Clin Endocrinol Metab. 1966 Mar;26(3):299-304 [4286018.001]
  • [Cites] Horm Metab Res. 1969 May;1(3):149-50 [4258876.001]
  • [Cites] Am J Med. 1981 May;70(5):1122-5 [7234878.001]
  • [Cites] J Clin Endocrinol Metab. 1985 Jan;60(1):21-8 [3964792.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Nov;83(11):3786-9 [9814447.001]
  • (PMID = 19915020.001).
  • [ISSN] 1945-7197
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 9002-60-2 / Adrenocorticotropic Hormone
  • [Other-IDs] NLM/ PMC2805485
  •  go-up   go-down


65. Lamprecht G, Baisch S, Schoenleber E, Gregor M: Transport properties of the human intestinal anion exchanger DRA (down-regulated in adenoma) in transfected HEK293 cells. Pflugers Arch; 2005 Feb;449(5):479-90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transport properties of the human intestinal anion exchanger DRA (down-regulated in adenoma) in transfected HEK293 cells.
  • Mutations in the down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea but the transport characteristics of human DRA have not been studied in a heterologous human expression system.
  • A N-terminal enhanced green fluorescence protein (EGFP)-tagged human DRA construct was therefore expressed stably in HEK293 cells.
  • [MeSH-minor] Bicarbonates / metabolism. Biological Transport / physiology. Cell Line. Cell Membrane / metabolism. Chloride-Bicarbonate Antiporters. Chlorides / metabolism. Cystic Fibrosis Transmembrane Conductance Regulator / genetics. Gene Expression. Green Fluorescent Proteins / genetics. Humans. Hydrogen-Ion Concentration. Kidney / cytology. Sulfates / metabolism. Transfection

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Physiol. 1985 Aug;249(2 Pt 1):G236-45 [3927745.001]
  • [Cites] J Biol Chem. 1993 Dec 5;268(34):25527-35 [8244988.001]
  • [Cites] J Clin Invest. 1975 Aug;56(2):302-10 [1150872.001]
  • [Cites] Am J Physiol Cell Physiol. 2000 Jul;279(1):C62-71 [10898717.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2001 Apr;280(4):G603-13 [11254486.001]
  • [Cites] J Physiol. 2003 May 15;549(Pt 1):3-19 [12651923.001]
  • [Cites] Am J Physiol. 1988 Dec;255 (6 Pt 1):C844-56 [2849306.001]
  • [Cites] Am J Physiol. 1999 Aug;277(2 Pt 1):G321-32 [10444446.001]
  • [Cites] Nat Cell Biol. 2004 Apr;6(4):343-50 [15048129.001]
  • [Cites] EMBO J. 2002 Nov 1;21(21):5662-72 [12411484.001]
  • [Cites] J Biol Chem. 1995 May 19;270(20):11897-902 [7744840.001]
  • [Cites] Pflugers Arch. 2001 Aug;442(5):709-17 [11512027.001]
  • [Cites] J Biol Chem. 1998 Nov 6;273(45):29972-8 [9792717.001]
  • [Cites] J Physiol. 1997 Mar 15;499 ( Pt 3):677-87 [9130164.001]
  • [Cites] Am J Physiol. 1994 Dec;267(6 Pt 2):H2114-23 [7810712.001]
  • [Cites] J Biol Chem. 1998 Oct 2;273(40):25856-63 [9748260.001]
  • [Cites] FEBS Lett. 1998 May 1;427(1):103-8 [9613608.001]
  • [Cites] Am J Physiol. 1985 Nov;249(5 Pt 1):G607-13 [4061648.001]
  • [Cites] J Biol Chem. 1993 Jan 5;268(1):206-11 [8380155.001]
  • [Cites] Am J Physiol. 1999 Jan;276(1 Pt 1):G7-G13 [9886972.001]
  • [Cites] J Biol Chem. 1999 May 21;274(21):14670-7 [10329661.001]
  • [Cites] Am J Physiol. 1996 Jan;270(1 Pt 1):G29-41 [8772498.001]
  • [Cites] Cancer Res. 2002 Sep 1;62(17):5083-8 [12208765.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2001 Nov;281(5):G1301-8 [11668039.001]
  • [Cites] Biochemistry. 2002 Oct 15;41(41):12336-42 [12369822.001]
  • [Cites] Protein Expr Purif. 1998 Feb;12(1):67-74 [9473459.001]
  • [Cites] Oncogene. 1996 Jan 18;12(2):387-96 [8570216.001]
  • [Cites] J Membr Biol. 1985;88(2):199-204 [3005584.001]
  • [Cites] Am J Physiol Cell Physiol. 2000 Jul;279(1):C40-50 [10898715.001]
  • [Cites] Gastroenterology. 2002 Mar;122(3):709-24 [11875004.001]
  • [Cites] Nat Genet. 1998 Jul;19(3):282-5 [9662405.001]
  • [Cites] Am J Physiol. 1983 Oct;245(4):G504-10 [6624918.001]
  • [Cites] Am J Physiol. 1992 Sep;263(3 Pt 1):G345-52 [1415547.001]
  • [Cites] Physiol Rev. 2002 Jan;82(1):245-89 [11773614.001]
  • [Cites] J Biol Chem. 1991 Jun 25;266(18):11448-54 [2050661.001]
  • [Cites] Gut. 2001 Apr;48(4):571-7 [11247905.001]
  • [Cites] J Biol Chem. 1999 Aug 6;274(32):22855-61 [10428871.001]
  • [Cites] J Biol Chem. 1999 Feb 5;274(6):3414-21 [9920885.001]
  • [Cites] Am J Physiol. 1999 Jan;276(1 Pt 1):G185-92 [9886994.001]
  • (PMID = 15480750.001).
  • [ISSN] 0031-6768
  • [Journal-full-title] Pflugers Archiv : European journal of physiology
  • [ISO-abbreviation] Pflugers Arch.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antiporters; 0 / Bicarbonates; 0 / CFTR protein, human; 0 / Chloride-Bicarbonate Antiporters; 0 / Chlorides; 0 / SLC26A3 protein, human; 0 / Sulfates; 126880-72-6 / Cystic Fibrosis Transmembrane Conductance Regulator; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


66. Ahmad S, Jielani AA, Khan K, Fatima T, Zia N, ud Duha M, Samad A, Memon K: Dual phase MIBI scintigraphy in diagnosis of parathyroid adenoma followed by ultrasound guided percutaneous alcoholic ablation. J Ayub Med Coll Abbottabad; 2008 Jul-Sep;20(3):149-51
Hazardous Substances Data Bank. ETHANOL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dual phase MIBI scintigraphy in diagnosis of parathyroid adenoma followed by ultrasound guided percutaneous alcoholic ablation.
  • Primary HPT is caused by parathyroid adenoma in 80-85% of patients.
  • Clinical manifestations are kidney stones, abdominal groans, painful bones, psychic moans, and fatigue overtones.
  • Ultrasonography is widely used in suspected cases for localization of parathyroid adenoma.
  • Dual phase Tc-99m MIBI scinitigraphy for detection of parathyroid adenomas has sensitivity and specificity values ranging from 82% to 100% and from 89% to 100%, respectively.
  • [MeSH-major] Adenoma / radionuclide imaging. Adenoma / therapy. Catheter Ablation / methods. Ethanol / therapeutic use. Parathyroid Neoplasms / radionuclide imaging. Parathyroid Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19610543.001).
  • [ISSN] 1025-9589
  • [Journal-full-title] Journal of Ayub Medical College, Abbottabad : JAMC
  • [ISO-abbreviation] J Ayub Med Coll Abbottabad
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 3K9958V90M / Ethanol; 971Z4W1S09 / Technetium Tc 99m Sestamibi
  •  go-up   go-down


67. Wang KL, Weinrach DM, Luan C, Han M, Lin F, Teh BT, Yang XJ: Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Hum Pathol; 2007 Feb;38(2):239-46
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
  • The precursor lesions of renal cell carcinoma (RCC) are unknown.
  • The purpose of this study is to determine the incidence, histomorphological features, and immunohistochemical features of papillary adenoma and elucidate its potential relationship to RCC.
  • Immunohistochemistry was carried out with antibodies specific for alpha-methyl-coenzyme A racemase (AMACR) and glutathione S-transferase alpha (clear-cell RCC marker).
  • Thirty-eight (7%) nephrectomy specimens showed histologic evidence of papillary adenoma.
  • Seven papillary adenomas (18%) occurred in the setting of acquired polycystic kidney disease (APKD), 6 in clear-cell RCCs, 3 in chromophobe RCCs, 2 in end-stage kidney disease, 1 in oncocytoma, 1 in angiomyolipoma, and 1 in renal schwannoma.
  • Furthermore, papillary adenomas were more commonly found in kidneys removed for PRCC (25%, 18/71) than in kidneys harboring clear-cell RCC (1.9%, 6/318).
  • Histomorphologically, papillary adenomas were characterized by varying proportions of papillae and tubules formed by cuboidal cells with scant basophilic cytoplasm similar to those in type 1 PRCC.
  • Adenomas associated with PRCC tend to be multiple in number (61% [11/18] of cases had >2 adenomas; mean, 5).
  • In contrast, 100% of papillary adenomas arising in other conditions had less than 2 adenomas.
  • Most of the adenomas (82%, 31/38) stained strongly for AMACR in a fashion similar to that of PRCC.
  • In this study of surgical specimens, the high coincidence, multifocality, and histologic and immunohistochemical similarities between papillary adenoma and PRCC suggest that the 2 are strongly associated and may represent a continuum of 1 biologic process.
  • In contrast, adenomas associated with APKD exhibit distinct morphological and immunohistochemical features and, therefore, may have an entirely different pathogenesis.
  • [MeSH-major] Carcinoma, Papillary / pathology. Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma, Clear Cell / enzymology. Adenocarcinoma, Clear Cell / pathology. Adenoma. Adenoma, Oxyphilic / enzymology. Adenoma, Oxyphilic / pathology. Adult. Aged. Aged, 80 and over. Angiomyolipoma / enzymology. Angiomyolipoma / pathology. Disease Progression. Female. Glutathione Transferase / analysis. Humans. Immunohistochemistry. Isoenzymes / analysis. Kidney / enzymology. Kidney / pathology. Kidney Failure, Chronic / enzymology. Kidney Failure, Chronic / pathology. Male. Middle Aged. Models, Biological. Polycystic Kidney Diseases / enzymology. Polycystic Kidney Diseases / pathology. Racemases and Epimerases / analysis

  • Genetic Alliance. consumer health - Papillary renal cell carcinoma.
  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17056094.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Isoenzymes; EC 2.5.1.18 / Glutathione Transferase; EC 2.5.1.18 / glutathione S-transferase alpha; EC 5.1.- / Racemases and Epimerases; EC 5.1.99.4 / alpha-methylacyl-CoA racemase
  •  go-up   go-down


68. Pacchioni D, Volante M, Casetta G, Sapino A, Marchiò C, Bussolati G: Myxoid renal tumor with myoepithelial differentiation mimicking a salivary gland pleomorphic adenoma: description of a case. Am J Surg Pathol; 2007 Apr;31(4):632-6
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myxoid renal tumor with myoepithelial differentiation mimicking a salivary gland pleomorphic adenoma: description of a case.
  • We herein report an unusual case of a low-grade myxoid renal epithelial neoplasm, with peculiar and previously unreported morphologic and immunohistochemical features.
  • These were lined by 2 different epithelial cell types, flat and elongated basal cells and cuboidal to spindle shaped eosinophilic luminal cells, with low-grade nuclear features and a few small nucleoli.
  • The lesion morphologically resembled a pleomorphic adenoma of the salivary gland.
  • The tumor proved benign at follow-up.
  • [MeSH-major] Kidney Neoplasms / pathology. Myoepithelioma / pathology. Neoplasms, Glandular and Epithelial / pathology
  • [MeSH-minor] Adenoma, Pleomorphic / pathology. Aged. Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Immunohistochemistry. Male. Salivary Gland Neoplasms / pathology

  • Genetic Alliance. consumer health - Salivary gland adenoma, pleomorphic.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17414112.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


69. National Toxicology Program: Toxicology and carcinogenesis studies of alpha-methylstyrene (Cas No. 98-83-9) in F344/N rats and B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser; 2007 Nov;(543):1-210
Hazardous Substances Data Bank. ALPHA-METHYL STYRENE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Kidney weights were significantly increased in 1,000 ppm males and 600 and 1,000 ppm females.
  • The incidences of renal hyaline droplet accumulation were similar between exposed groups and chamber control groups, but the severity of hyaline droplet accumulation in 600 and 1,000 ppm males was greater than in chamber controls.
  • Morphologic changes were not detected in the liver.
  • Two 1,000 ppm males and one 300 ppm male had renal tubule carcinomas, and one 300 ppm male had a renal tubule adenoma.
  • Because of the neoplasms observed in 300 and 1,000 ppm males at the end of the 2-year study and the finding of alpha2μ-globulin accumulation in the kidneys at 3 months, which is often associated with kidney neoplasms, additional step sections of kidney were prepared; additional males with focal hyperplasia or adenoma were identified.
  • The incidences of renal tubule adenoma and carcinoma (combined) in the 1,000 ppm males were significantly greater than those in the chamber controls when the single and step sections were combined.
  • The incidence of mineralization of the renal papilla was significantly increased in 1,000 ppm males.
  • The incidence of mononuclear cell leukemia in 1,000 ppm males was significantly increased compared to the chamber controls.
  • In the nose, the incidences of basal cell hyperplasia were significantly increased in all exposed groups of males and females, and the incidences of degeneration of the olfactory epithelium were increased in 1,000 ppm males and females and 300 ppm females.
  • The incidences of hepatocellular adenoma or carcinoma (combined) were significantly increased in the 100 and 600 ppm males and in all exposed groups of females.
  • The incidences of hepatocellular adenoma were significantly increased in all exposed groups of females, and the incidences in all exposed groups of males and females exceeded the historical range for chamber controls.
  • CONCLUSIONS: Under the conditions of this 2-year inhalation study, there was some evidence of carcinogenic activity of alpha-methylstyrene in male F344/N rats based on increased incidences of renal tubule adenomas and carcinomas (combined).
  • The increased incidence of mononuclear cell leukemia in 1,000 ppm male F344/N rats may have been related to alpha-methylstyrene exposure.
  • There was equivocal evidence of carcinogenic activity of alpha-methylstyrene in male B6C3F1 mice based on marginally increased incidences of hepatocellular adenoma or carcinoma (combined).
  • There was clear evidence of carcinogenic activity of alpha-methylstyrene in female B6C3F1 mice based on increased incidences of hepatocellular adenomas and carcinomas.
  • Exposure of rats to alpha-methylstyrene resulted in kidney toxicity, which in males exhibited some features of alpha2μ-globulin nephropathy.
  • Exposure to alpha-methylstyrene resulted in nonneoplastic lesions of the nose in male and female rats and mice and of the liver and kidney in female mice.
  • [MeSH-minor] Animals. Body Weight / drug effects. CHO Cells. Cricetinae. Cricetulus. DNA Damage. Female. Inhalation Exposure. Kidney / drug effects. Kidney / pathology. Kidney Neoplasms / chemically induced. Kidney Neoplasms / pathology. Leukemia, Myeloid / chemically induced. Leukemia, Myeloid / pathology. Liver Neoplasms / chemically induced. Liver Neoplasms / pathology. Male. Mice. Mice, Inbred Strains. Micronuclei, Chromosome-Defective / chemically induced. Nose Diseases / chemically induced. Rats. Rats, Inbred F344

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18685715.001).
  • [ISSN] 0888-8051
  • [Journal-full-title] National Toxicology Program technical report series
  • [ISO-abbreviation] Natl Toxicol Program Tech Rep Ser
  • [Language] eng
  • [Publication-type] Journal Article; Technical Report
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Air Pollutants, Occupational; 0 / Carcinogens; 0 / Mutagens; 0 / Styrenes; 98-83-9 / alpha-methylstyrol
  •  go-up   go-down


70. Mahadevia S, Rozenblit A, Milikow D, Marinovich A: Renal-adrenal fusion: instance of an adrenal adenoma mimicking a solid renal mass at CT--case report. Radiology; 2009 Jun;251(3):808-12
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal-adrenal fusion: instance of an adrenal adenoma mimicking a solid renal mass at CT--case report.
  • The authors report an unusual case of unilateral renal-adrenal fusion with a concurrent adrenal adenoma.
  • At computed tomography, this abnormality appeared as a solid enhancing lesion in the upper pole of the kidney, mimicking a renal mass.
  • [MeSH-major] Adrenal Cortex Neoplasms / radiography. Adrenocortical Adenoma / radiography. Kidney / abnormalities. Tomography, X-Ray Computed
  • [MeSH-minor] Aged. Contrast Media. Diagnosis, Differential. Female. Humans. Iohexol / analogs & derivatives. Kidney Diseases / radiography. Nephrectomy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19261923.001).
  • [ISSN] 1527-1315
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 4419T9MX03 / Iohexol; 712BAC33MZ / iopromide
  •  go-up   go-down


71. Olgac S, Hutchinson B, Tickoo SK, Reuter VE: Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod Pathol; 2006 Feb;19(2):218-24
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
  • Metanephric adenoma (MA), a well-described renal neoplasm, usually behaves in a benign fashion.
  • It may have areas that are morphologically similar to papillary renal cell carcinoma (RCC) type, or epithelial (tubular predominant) type Wilms' tumor.
  • Recent microarray analysis of renal tumors has shown an increase of AMACR mRNA levels in papillary RCC but not in other subtypes.
  • In conclusion, diffuse and strong immunoreactivity for AMACR may be useful in differentiating papillary RCC from MA but a panel which includes AMACR, CK7 and CD57 is better in this differential diagnosis.
  • AMACR is not helpful in differentiating MA from Wilms' tumor, but CD57 is helpful in this differential diagnosis.
  • [MeSH-major] Adenoma / pathology. Biomarkers, Tumor / analysis. Kidney Neoplasms / pathology. Racemases and Epimerases / analysis
  • [MeSH-minor] Antigens, CD57 / analysis. Carcinoma, Papillary / enzymology. Carcinoma, Papillary / pathology. Carcinoma, Renal Cell / enzymology. Carcinoma, Renal Cell / pathology. Diagnosis, Differential. Humans. Immunohistochemistry. Keratin-7. Keratins / analysis. WT1 Proteins / analysis. Wilms Tumor / enzymology. Wilms Tumor / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16424894.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD57; 0 / Biomarkers, Tumor; 0 / KRT7 protein, human; 0 / Keratin-7; 0 / WT1 Proteins; 68238-35-7 / Keratins; EC 5.1.- / Racemases and Epimerases; EC 5.1.99.4 / alpha-methylacyl-CoA racemase
  •  go-up   go-down


72. Tian L, Guo Y, Wu YP, Liu LZ: [CT features of adrenal cortical adenoma: a report of 109 cases]. Ai Zheng; 2008 Jan;27(1):66-70

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [CT features of adrenal cortical adenoma: a report of 109 cases].
  • BACKGROUND & OBJECTIVE: Adrenal cortical adenoma (ACA) is a common disease, and can be diagnosed easily with CT examination.
  • However, some atypical adenomas are likely to be misdiagnosed.
  • RESULTS: Of the 109 cases of ACA, 104 showed unilateral single adenoma, 1 showed unilateral 2 adenomas, and 4 showed bilateral adenomas.
  • The maximal diameter of non-functional adenomas was larger than that of Cushing's adenomas, and the latter was larger than that of Conn's adenomas.
  • The probability of degeneration was higher in large adenomas than in small adenomas.
  • Two patients had recurrence after operation: 1 showed infiltration in the adjacent kidney and the psoas major on pathologic examination, 1 showed infiltration in the liver and thoracic vertebra on CT images.
  • [MeSH-major] Adrenal Cortex Neoplasms / radiography. Adrenocortical Adenoma / radiography. Radiographic Image Enhancement / methods. Tomography, Spiral Computed / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Infant. Male. Middle Aged. Neoplasm Recurrence, Local. Tumor Burden. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18184467.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


73. Amodio JB, Shapiro E, Pinkney L, Rivera R, Strubel N, Douglas D, Fefferman N: Metanephric adenoma in an 8-year-old child: case report and review of the literature. J Pediatr Surg; 2005 May;40(5):e25-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma in an 8-year-old child: case report and review of the literature.
  • Metanephric adenoma (MA) is a renal tumor that is rarely found in children.
  • There are certain imaging features of MA that may suggest the diagnosis preoperatively.
  • Metanephric adenoma is often hyperechoic on sonography, hyperdense on noncontrast computed tomography scans, and of low signal intensity on T1- and T2-weighted magnetic resonance images.
  • However, the distinction of MA from other metanephric lesions as well as from Wilms' tumor and papillary renal cell carcinoma may not be readily apparent at the time of surgery.
  • [MeSH-major] Adenoma / surgery. Kidney Neoplasms / surgery
  • [MeSH-minor] Appendicitis / radiography. Carcinoma, Renal Cell / diagnosis. Child. Diagnosis, Differential. Female. Humans. Incidental Findings. Magnetic Resonance Imaging. Nephrectomy. Tomography, X-Ray Computed. Wilms Tumor / diagnosis

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15937802.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 15
  •  go-up   go-down


74. Linder B, Hong Y, Jarrett T: Intra-renal adrenal adenoma: a compelling addition to the differential diagnosis of renal mass. Int J Urol; 2009 Nov;16(11):912-4
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for adrenal adenoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intra-renal adrenal adenoma: a compelling addition to the differential diagnosis of renal mass.
  • We report a case of an adrenal rest arising in the kidney of a 37-year-old male.
  • Laparoscopic renal exploration and biopsy revealed angiomyolipoma on frozen section.
  • However, final pathological analysis of the partial nephrectomy specimen revealed intra-renal adrenal adenoma.
  • The diagnosis was confirmed by immunohistochemistries and transmission electron microscopy.
  • We review the reported literature on intra-renal adrenal adenoma and highlight the aspects that raise the index of suspicion for this entity on the differential diagnosis of renal masses.
  • [MeSH-major] Adenoma / diagnosis. Adrenal Gland Neoplasms / diagnosis. Kidney Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19863627.001).
  • [ISSN] 1442-2042
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Australia
  • [Number-of-references] 8
  •  go-up   go-down


75. Bastos Netto JM, Esteves TC, Mattos Rde C, Tibiriçá SH, Costa SM, Vieira LJ: Metanephric adenoma: a rare differential diagnosis of renal tumor in children. J Pediatr Urol; 2007 Aug;3(4):340-1

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma: a rare differential diagnosis of renal tumor in children.
  • Metanephric adenoma is an extremely rare tumor of the kidney.
  • The clinical and anatomic characteristics are not yet well defined, but it is currently considered to be a benign tumor with a good prognosis, although recently two metastatic cases have been reported.
  • We present here the youngest girl yet to be reported with a diagnosis of metanephric adenoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18947770.001).
  • [ISSN] 1873-4898
  • [Journal-full-title] Journal of pediatric urology
  • [ISO-abbreviation] J Pediatr Urol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


76. Kojima Y, Miyake O, Morimoto A, Kawamura C, Katayama S: [A case of aldosterone-producing adenoma associated with end-stage renal disease]. Hinyokika Kiyo; 2010 Jan;56(1):21-4
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of aldosterone-producing adenoma associated with end-stage renal disease].
  • Periodic follow-up abdominal ultrasonography revealed a tumor measuring 4 cm in diameter in an area adjacent to the upper pole of the right kidney.
  • Under a diagnosis of aldosterone-producing adrenal tumor, laparoscopic right adrenalectomy was performed.
  • Pathological findings showed adrenal cortical adenoma.
  • A previous study also indicated the presence of hyperaldosteronemia in patients with end-stage renal disease.
  • A diagnosis should be carefully made.
  • [MeSH-major] Adenoma / complications. Adrenal Gland Neoplasms / complications. Aldosterone / biosynthesis. Kidney Failure, Chronic / complications

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Failure.
  • Hazardous Substances Data Bank. POTASSIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20104005.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone; RWP5GA015D / Potassium
  •  go-up   go-down


77. Portugal R, Barroca H: Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour. Cytopathology; 2008 Apr;19(2):80-5
MedlinePlus Health Information. consumer health - Wilms Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour.
  • Wilms' Tumour (WT) is the most common kidney tumour in childhood, this fact and the embryonic complexity of WT create, whenever one of its three classical components predominates in cytologic smears, difficulties in the differential diagnoses with other less common entities.
  • In the present study, we review the cytological and immunohistochemical characteristics of three children renal tumours, a Clear Cell Sarcoma of the Kidney (CCSK-case1), a Cellular Mesoblastic Nephroma (CMN-case2) and a Metanephric Adenoma (MA-case3) and compare them, for differential diagnostic purposes, with smears of blastematous, mesenchymal and epithelial predominant WTs, previously diagnosed in our Department.
  • The presence of moderate amount of blue pale cytoplasm in neoplastic cells (case1), the presence of tightly cohesive, bland, spindle tumour cells (case2) and the identification of small, well differentiated epithelial tubules with psammoma bodies in case 3, were the main morphologic characteristics that we think represent the most important elements for distinguishing our cases from a WT.
  • Summing up, these three cases demonstrate that cytopathologists should be aware of the occurrence of uncommon renal neoplasms in childhood and should be acquainted with their characteristics, in order to avoid false diagnoses.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology. Nephroma, Mesoblastic / pathology. Sarcoma, Clear Cell / pathology. Wilms Tumor / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor. Biopsy, Fine-Needle. Child. Child, Preschool. Cytoplasm / chemistry. Cytoplasm / pathology. Diagnosis, Differential. Female. Humans. Inclusion Bodies / chemistry. Inclusion Bodies / pathology. Infant, Newborn. Male. Pregnancy

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17681013.001).
  • [ISSN] 1365-2303
  • [Journal-full-title] Cytopathology : official journal of the British Society for Clinical Cytology
  • [ISO-abbreviation] Cytopathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


78. National Toxicology Program: NTP toxicology and carcinogenesis studies of decalin (CAS No. 91-17-8) in F344/N rats and B6C3F(1) mice and a toxicology study of decalin in male NBR rats (inhalation studies). Natl Toxicol Program Tech Rep Ser; 2005 Jan;(513):1-316
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Male NBR rats do not produce alpha2u-globulin; the NBR rats were included to study the relationship of alpha2u-globulin and renal lesion induction.
  • Renal toxicity studies were performed in male F344/N and NBR rats.
  • The numbers of labeled cells and the labeling indices in the left kidney of 200 and 400 ppm F344/N male rats were significantly greater than those in the chamber controls.
  • Kidney weights of male F344/N rats exposed to 50 ppm or greater were significantly increased.
  • Exposure-related hyaline droplet accumulation, degeneration and regeneration of renal cortical tubules, and granular casts occurred in the kidney of exposed F344/N male rats.
  • 3-MONTH STUDY IN RATS: Groups of 25 male and 20 female F344/N rats were exposed to 0, 25, 50, 100, 200, or 400 ppm decalin vapor 6 hours per day, 5 days per week for 2 (five male renal toxicity rats), 6 (10 male and 10 female clinical pathology rats), or 14 (10 core study rats) weeks.
  • Urinalysis results indicated that decalin exposure caused increases in urine glucose and protein concentrations and enzyme activities that were consistent with the renal lesions observed microscopically.
  • Renal toxicity studies were performed on rats sacrificed at 2 and 6 weeks and at the end of the study.
  • In kidney tissue examined for cell proliferation, the numbers of PCNA-labeled cells and labeling indices were generally significantly greater than those of the chamber controls in exposed groups of rats at all three time points.
  • Concentrations of alpha2u-globulin in the kidney as well as the alpha2u-globulin/soluble protein ratios were significantly increased at week 2 in all exposed groups and in the 200 and 400 ppm groups at week 6 and at the end of the study.
  • Absolute and/or relative kidney and liver weights of male rats exposed to 50 ppm or greater were increased.
  • Incidences of renal tubule regeneration and granular casts in the medulla of the kidney in exposed male rats were increased, and the severities of hyaline droplets generally increased with increasing exposure concentration.
  • Incidences of renal tubule adenoma and adenoma or carcinoma (combined) and of benign or malignant pheochromocytoma (combined) of the adrenal medulla in 100 and 400 ppm males were significantly increased.
  • Nonneoplastic lesions related to decalin exposure occurred in the kidney of male rats.
  • CONCLUSIONS: Under the conditions of these studies, there was clear evidence of carcinogenic activity of decalin in male F344/N rats based on increased incidences of renal tubule neoplasms.
  • The increased incidences of benign or malignant pheochromocytoma (combined) of the adrenal medulla in male rats were also considered to be exposure related.
  • Exposure of male rats to decalin resulted in nonneoplastic lesions of the kidney characteristic of alpha2u-globulin accumulation.
  • [MeSH-minor] Administration, Inhalation. Animal Feed / analysis. Animals. Atmosphere Exposure Chambers. Body Weight / drug effects. Female. Genitalia, Male / pathology. Kidney Diseases / chemically induced. Kidney Diseases / pathology. Male. Mice. Mice, Inbred Strains. Mutagens / toxicity. Organ Size / drug effects. Rats. Rats, Inbred F344. Reproduction / drug effects

  • Hazardous Substances Data Bank. DECAHYDRONAPHTHALENE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15891779.001).
  • [ISSN] 0888-8051
  • [Journal-full-title] National Toxicology Program technical report series
  • [ISO-abbreviation] Natl Toxicol Program Tech Rep Ser
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Mutagens; 0 / Naphthalenes; 88451Q4XYF / decalin
  •  go-up   go-down


79. Küpeli S, Baydar DE, Canakl F, Yalçn B, Kösemehmetoğlu K, Tekgül S, Büyükpamukçu M: Metanephric adenoma in a 6-year-old child with hemihypertrophy. J Pediatr Hematol Oncol; 2009 Jun;31(6):453-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma in a 6-year-old child with hemihypertrophy.
  • Metanephric adenoma (MA) is a renal tumor that is rarely diagnosed in children.
  • Although it is considered benign and to have a good prognosis, the diagnosis of MA is challenging because of histopathologic and radiologic similarities to Wilms tumor.
  • In this case report, we present a 6-year-old girl, with a renal mass and right hemihypertrophy, who was previously diagnosed as Wilms tumor on a fine-needle biopsy and diagnosed as MA after nephroureterectomy.
  • The differentiation between Wilms tumor and metanephric adenoma is also discussed.
  • [MeSH-major] Adenoma / pathology. Biopsy, Fine-Needle. Kidney Neoplasms / pathology. Wilms Tumor / pathology
  • [MeSH-minor] Child. Diagnosis, Differential. Diagnostic Errors. Female. Humans. Immunohistochemistry. Nephrectomy. Ureter / surgery

  • Genetic Alliance. consumer health - Hemihypertrophy.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Wilms Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19648796.001).
  • [ISSN] 1536-3678
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Fulciniti F, Losito NS, Botti G, Manola M, Ionna F: Spontaneous infarction of pleomorphic adenoma: report of a case simulating malignancy on fine-needle cytology sample. Diagn Cytopathol; 2010 Jun;38(6):430-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spontaneous infarction of pleomorphic adenoma: report of a case simulating malignancy on fine-needle cytology sample.
  • Ischemic or hemorrhagic infarction has been described as an uncommon but possible complication of fine-needle cytology sampling in numerous organs, more frequently the thyroid, the salivary glands, the breast, the lymph node, and the kidney.
  • One case of a spontaneous infarction of a parotid pleomorphic adenoma in a 46-year-old lady is here described in which the cytopathologic findings, which were related to ischemic infarction, preceded fine-needle cytology sampling and mimicked malignancy.
  • [MeSH-major] Adenoma, Pleomorphic / blood supply. Adenoma, Pleomorphic / pathology. Infarction / pathology. Parotid Neoplasms / blood supply. Parotid Neoplasms / pathology
  • [MeSH-minor] Biopsy, Fine-Needle / adverse effects. Carcinoma, Mucoepidermoid / pathology. Carcinoma, Squamous Cell / pathology. Diagnosis, Differential. Female. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Wiley-Liss, Inc.
  • (PMID = 19894261.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Khayyata S, Grignon DJ, Aulicino MR, Al-Abbadi MA: Metanephric adenoma vs. Wilms' tumor: a report of 2 cases with diagnosis by fine needle aspiration and cytologic comparisons. Acta Cytol; 2007 May-Jun;51(3):464-7
MedlinePlus Health Information. consumer health - Wilms Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma vs. Wilms' tumor: a report of 2 cases with diagnosis by fine needle aspiration and cytologic comparisons.
  • BACKGROUND: Metanephric adenoma (MA) is a rare benign renal neoplasm that can occur at any age, whereas, Wilms' tumor (WT) is the most common malignant renal neoplasm in children and is occasionally seen in adults.
  • CASES: In case 1, a 26-year-old male had a left renal mass.
  • The cytologic differential diagnosis included Wilms' tumor, neuroectodermal tumor and metanephric adenoma.
  • In case 2, a 24-year-old female presented with erythrocytosis and a right renal mass.
  • A diagnosis of metanephric adenoma was made and confirmed on nephrectomy.
  • [MeSH-major] Adenoma / diagnosis. Adenoma / pathology. Kidney Neoplasms / diagnosis. Kidney Neoplasms / pathology. Wilms Tumor / diagnosis. Wilms Tumor / pathology
  • [MeSH-minor] Adult. Biopsy, Fine-Needle. Cell Nucleolus / pathology. Cell Nucleus Shape. Diagnosis, Differential. Female. Humans. Kidney / pathology. Kidney / surgery. Male. Nephrectomy


82. Patel NP, Geisinger KR, Zagoria RJ, Bergman S: Fine needle aspiration biopsy of metanephric adenoma: a case report. Acta Cytol; 2009 May-Jun;53(3):327-31
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration biopsy of metanephric adenoma: a case report.
  • BACKGROUND: Metanephric adenoma (MA) is a rare, benign renal neoplasm.
  • Regarding treatment, radioflrequency ablation (RFA) is an emerging alternative to surgical resection of renal neoplasms in appropriately selected patients.
  • CASE: A 49-year-old woman had a 3.3-cm cortical mass in the left kidney.
  • The aspirate smears displayed multiple aggregates of benign-appearing, tightly packed and overlapping nuclei surrounded by basement membrane- type material.
  • Although the differential diagnosis included adult Wilms' tumor and papillary renal cell carcinoma, the bland morphology and IHC staining pattern strongly favored a neoplasm consistent with MA.
  • CONCLUSION: FNAB can be used to diagnose most renal neoplasms.
  • A diagnosis of MA can be suggested on FNAB in the context of appropriate cytomorphology, IHC staining and cytogenetic analysis.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology
  • [MeSH-minor] Antigens, CD57 / analysis. Biomarkers, Tumor / analysis. Biopsy, Fine-Needle. Carcinoma, Renal Cell / diagnosis. Carcinoma, Renal Cell / secondary. Catheter Ablation / methods. Diagnosis, Differential. Female. Humans. Middle Aged. Minimally Invasive Surgical Procedures. Treatment Outcome. WT1 Proteins / analysis. Wilms Tumor / diagnosis

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19534278.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD57; 0 / Biomarkers, Tumor; 0 / WT1 Proteins
  •  go-up   go-down


83. Mahe E, El-Shinnawy I: A "tumour trifecta:" myelolipomata arising within an adrenocortical adenoma ipsilateral to a synchronous clear cell renal cell carcinoma. Malays J Pathol; 2010 Dec;32(2):123-8
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A "tumour trifecta:" myelolipomata arising within an adrenocortical adenoma ipsilateral to a synchronous clear cell renal cell carcinoma.
  • We present an intriguing case of adrenal myelolipomata occurring within an adrenocortical adenoma in concert with an ipsilateral clear cell renal cell carcinoma.
  • Computed tomography indicated a 2.5 cm right renal mass as well as a 5 cm right adrenal mass.
  • Histology of the renal mass was consistent with conventional clear cell renal cell carcinoma, Fuhrman grade III.
  • There was no extra-renal extension or lymphovascular invasion.
  • The adrenal mass was a cortical adenoma with solid and nested patterns, with discrete zones consisting of erythroid, myeloid and megakaryocytic cells intermixed with mature adipocytes.
  • [MeSH-major] Adrenal Cortex Neoplasms / pathology. Adrenocortical Adenoma / pathology. Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology. Myelolipoma / pathology. Neoplasms, Multiple Primary / pathology


84. Rodrigues S, Rodrigue CM, Attoub S, Fléjou JF, Bruyneel E, Bracke M, Emami S, Gespach C: Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells. Oncogene; 2006 Oct 26;25(50):6628-36
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells.
  • To examine the transforming potential of TFF1 in human colon epithelial cells, premalignant PC/AA/C1 adenoma cells (PC) derived from a patient with familial adenomatous polyposis (FAP) were transformed by the TFF1 cDNA and used as a model of the adenoma-carcinoma transition.
  • Constitutive expression of TFF1 increased anchorage-independent cell growth in soft agar, and induced or potentiated the growth of colon PC-TFF1 and kidney MDCKts.src-TFF1 tumor xenografts in athymic mice.
  • Using the differential display approach to identify TFF1 target genes, we found that the dual specific phosphatases Cdc25A and B implicated in cell cycle transitions are strongly upregulated under active forms in both PC-TFF1 and HCT8/S11-TFF1 colon cancer cells.
  • Accordingly, TFF1 expression is absent in normal human colon crypts but is induced in correlation with Cdc25a and b transcript levels and tumor grade in familial and sporadic colon adenomas and carcinomas.
  • We propose that TFF1 and Cdc25A-B cooperate with other dominant oncogenic pathways to induce the adenoma and adenocarcinoma transitions.
  • [MeSH-major] Adenoma / pathology. Carcinoma / pathology. Cell Cycle Proteins / metabolism. Colon / cytology. Colonic Neoplasms / pathology. Intestinal Mucosa / metabolism. Tumor Suppressor Proteins / physiology. cdc25 Phosphatases / metabolism
  • [MeSH-minor] Animals. Cell Adhesion / genetics. Cell Proliferation. Cell Survival. Cell Transformation, Neoplastic / genetics. Colorectal Neoplasms / metabolism. Disease Progression. Dogs. Enzyme Induction. Gene Expression Regulation, Neoplastic. Humans. Mice. Mice, Nude. Neoplasm Invasiveness / genetics. Phenotype. Precancerous Conditions / pathology. Transfection. Transplantation, Heterologous. Tumor Cells, Cultured

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16715141.001).
  • [ISSN] 0950-9232
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / TFF1 protein, human; 0 / Tumor Suppressor Proteins; EC 3.1.3.16 / CDC25B protein, human; EC 3.1.3.16 / Cdc25a protein, mouse; EC 3.1.3.48 / CDC25A protein, human; EC 3.1.3.48 / cdc25 Phosphatases
  •  go-up   go-down


85. National Toxicology Program: Toxicology and carcinogenesis studies of divinylbenzene-HP (Cas No. 1321-74-0) in F344/N rats and B6C3F1 mice (inhalation studies). Natl Toxicol Program Tech Rep Ser; 2006 Nov;(534):1-290
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Relative kidney weights of 50 ppm or greater males and relative liver weights of 200 and 400 ppm males were significantly greater than those of the chamber controls.
  • Kidney and liver weights of exposed groups of females were significantly greater than those of the chamber controls.
  • Renal tubule necrosis and regeneration occurred at 200 ppm.
  • Kidney and liver weights of exposed groups of males and of 400 ppm females were generally greater than those of the chamber controls.
  • Incidences of degeneration of the olfactory epithelium in 200 and 400 ppm rats and basal cell hyperplasia of the olfactory epithelium in rats exposed to 100 ppm or greater were significantly increased.
  • Exposure to divinylbenzene was associated with necrosis of the liver and kidney in 200 ppm males and females dying early.
  • Renal tubule carcinomas occurred in two of 50 males exposed to 400 ppm in the original kidney sections, an incidence that exceeded the historical control range.
  • In 400 ppm males, the incidence of renal tubule hyperplasia was increased, and the incidence of nephropathy was significantly increased.
  • Following combined analysis of single and step-section data, the incidences of renal tubule adenoma and adenoma or carcinoma (combined) were marginally higher in 200 and 400 ppm males, and the incidence of renal tubule hyperplasia was significantly increased in 400 ppm males.
  • The incidences of malignant glial cell tumors (malignant astrocytoma and oligodendroglioma) in the brain were slightly increased in 100 and 200 ppm males, and the incidence in the 200 ppm group exceeded the historical range for chamber controls.
  • The incidences of alveolar/bronchiolar adenoma and alveolar/bronchiolar adenoma or carcinoma (combined) in 100 ppm males were greater than chamber control incidences, but the incidences of adenoma or carcinoma (combined) were within the historical control range.
  • The incidences of alveolar/bronchiolar adenoma and alveolar/bronchiolar adenoma or carcinoma (combined) in all exposed groups of females were generally greater than those of the chamber controls; the incidences were at the upper end or exceeded the historical control ranges.
  • CONCLUSIONS: Under the conditions of this 2-year inhalation study, there was equivocal evidence of carcinogenic activity of divinylbenzene-HP in male F344/N rats based upon the occurrence of carcinomas in the kidney and glial tumors in the brain.
  • There was equivocal evidence of carcinogenic activity of divinylbenzene-HP in female B6C3F1 mice based on the incidences of alveolar/bronchiolar adenoma or carcinoma (combined) in the lung.
  • [MeSH-minor] Animals. Dose-Response Relationship, Drug. Female. Inhalation Exposure. Kidney / drug effects. Kidney / pathology. Liver / drug effects. Liver / pathology. Male. Mice. Mice, Inbred Strains. Organ Size / drug effects. Rats. Rats, Inbred F344

  • Hazardous Substances Data Bank. VINYLSTYRENE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17342197.001).
  • [ISSN] 0888-8051
  • [Journal-full-title] National Toxicology Program technical report series
  • [ISO-abbreviation] Natl Toxicol Program Tech Rep Ser
  • [Language] eng
  • [Publication-type] Journal Article; Technical Report
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Vinyl Compounds; IZ715T4SBU / divinyl benzene
  •  go-up   go-down


86. Zhang FW, Cheng HC, Jiang CD, Deng CY, Xiong YZ, Li FE, Lei MG: Imprinted status of pleomorphic adenoma gene-like I and paternal expression gene 10 genes in pigs. J Anim Sci; 2007 Apr;85(4):886-90

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imprinted status of pleomorphic adenoma gene-like I and paternal expression gene 10 genes in pigs.
  • In this study, the polymorphism-based approach was used to detect the expression patterns of the porcine pleomorphic adenoma gene-like I (PLAGL1) and paternal expression gene 10 (PEG10) genes.
  • Imprinting analysis indicated that the PLAGL1 and PEG10 genes were both paternally expressed in all tissues tested (heart, liver, spleen, lung, kidney, stomach, small intestine, skeletal muscle, fat, uterus, and ovary).
  • [MeSH-major] Cell Cycle Proteins / genetics. Genomic Imprinting / genetics. Swine / genetics. Transcription Factors / genetics. Tumor Suppressor Proteins / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17178803.001).
  • [ISSN] 1525-3163
  • [Journal-full-title] Journal of animal science
  • [ISO-abbreviation] J. Anim. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Transcription Factors; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


87. Tinmouth WW, Habib E, Kim SC, Kuo RL, Paterson RF, Terry CL, Elhilali M, Lingeman JE: Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol; 2005 Jun;19(5):550-4
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection?
  • BACKGROUND AND PURPOSE: Holmium laser enucleation of the prostate (HoLEP) is a well-established technique for the treatment of benign prostatic hyperplasia (BPH).
  • RESULTS: The average weight of adenoma resected was 49.8 g (range 5-300 g) in the McGill group and 90.4 g (range 7.9-312 g) in the Methodist Hospital group.
  • Log transformed preoperative PSA correlated well with TRUS volume (r = 0.45), as did the weight of adenoma resected with absolute change in PSA (r = 0.38).
  • CONCLUSION: The HoLEP procedure produces a significant diminution in PSA that correlates well with the weight of adenoma resected.
  • Measurement of PSA may be a useful tool for the objective assessment of ablative therapies for BPH, as the reduction in PSA corresponds well with the amount of adenoma removed.


88. Kahveci A, Ari E, Arikan H, Koc M, Tuglular S, Ozener C: Streptococcus bovis bacteremia related to colon adenoma in a chronic hemodialysis patient. Hemodial Int; 2010 Jan;14(1):91-3
MedlinePlus Health Information. consumer health - Streptococcal Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Streptococcus bovis bacteremia related to colon adenoma in a chronic hemodialysis patient.
  • Abstract We report the case of a 54-year-old hemodialysis patient who presented with recurrent fever due to Streptococcus bovis bacteremia related to colonic tubulovillous adenoma.
  • In this paper, we discussed the relation between S. bovis bacteremia, colonic adenomas, and hemodialysis.
  • Awareness of this association is critical for early diagnosis and management.
  • [MeSH-major] Adenoma / microbiology. Bacteremia / etiology. Colonic Neoplasms / microbiology. Kidney Failure, Chronic / therapy. Renal Dialysis / adverse effects. Streptococcal Infections / pathology. Streptococcus bovis / isolation & purification

  • MedlinePlus Health Information. consumer health - Dialysis.
  • MedlinePlus Health Information. consumer health - Kidney Failure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19758303.001).
  • [ISSN] 1542-4758
  • [Journal-full-title] Hemodialysis international. International Symposium on Home Hemodialysis
  • [ISO-abbreviation] Hemodial Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


89. Puppa G, Gervasio A, Yorukoglu K, Colombari R, De Marchi F, Canzonieri V: Huge renal cyst with parietal renal cell carcinoma, osseous metaplasia and a papillary adenoma: a case report with unique clinicopathological features and literature review. Virchows Arch; 2008 Mar;452(3):325-30
MedlinePlus Health Information. consumer health - Kidney Cysts.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Huge renal cyst with parietal renal cell carcinoma, osseous metaplasia and a papillary adenoma: a case report with unique clinicopathological features and literature review.
  • The unique clinicopathological features of a giant solitary renal cyst with a parietal clear cell carcinoma in contiguity with a focus of osseous metaplasia and a papillary adenoma are reported.
  • During surgery, a frozen section revealed the presence of a renal cell carcinoma of clear cell type, so a nephrectomy was performed.
  • After extensive pathological sampling of the cyst's wall, a focus of osseous metaplasia in contiguity with the main tumour and a microscopic papillary adenoma were found.
  • [MeSH-major] Adenoma / pathology. Carcinoma, Renal Cell / pathology. Kidney Diseases, Cystic / pathology. Kidney Neoplasms / pathology
  • [MeSH-minor] Humans. Immunohistochemistry. Keratin-7 / analysis. Kidney / chemistry. Kidney / diagnostic imaging. Male. Metaplasia. Middle Aged. Neprilysin / analysis. Radiography. Ultrasonography

  • Genetic Alliance. consumer health - Papillary renal cell carcinoma.
  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1991 May;179(2):307-17 [2014269.001]
  • [Cites] Kidney Int. 2005 Feb;67(2):774-5 [15673329.001]
  • [Cites] Br J Urol. 1997 Sep;80(3):495-6 [9313678.001]
  • [Cites] Radiology. 1986 Jan;158(1):1-10 [3510019.001]
  • [Cites] J Urol. 1990 Apr;143(4):797-9 [2179585.001]
  • [Cites] J Urol. 1977 Jun;117(6):704-7 [875143.001]
  • [Cites] Arch Pathol Lab Med. 1984 Feb;108(2):138-40 [6546494.001]
  • [Cites] Int Urol Nephrol. 1996;28(2):141-4 [8836779.001]
  • [Cites] J Clin Pathol. 1977 Sep;30(9):868-77 [915015.001]
  • [Cites] Hum Pathol. 2007 Feb;38(2):239-46 [17056094.001]
  • [Cites] Am J Clin Pathol. 1983 Feb;79(2):238-42 [6823908.001]
  • [Cites] J Urol. 1977 Nov;118(5):861-2 [916119.001]
  • [Cites] J Urol. 2007 Jan;177(1):343 [17162087.001]
  • [Cites] Br J Urol. 1975 Apr;47(2):152 [1148614.001]
  • [Cites] Urology. 1986 Aug;28(2):145-53 [3739121.001]
  • [Cites] Urology. 2003 Feb;61(2):462 [12597974.001]
  • [Cites] Adv Anat Pathol. 2006 Jan;13(1):26-56 [16462154.001]
  • [Cites] J Urol. 1986 Aug;136(2):449-51 [3735516.001]
  • [Cites] Abdom Imaging. 1996 Jan-Feb;21(1):71-2 [8672979.001]
  • (PMID = 18080136.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Keratin-7; EC 3.4.24.11 / Neprilysin
  • [Number-of-references] 19
  •  go-up   go-down


90. Lunn MR, Muñoz Mendoza J, Pasche LJ, Norton JA, Ayco AL, Chertow GM: Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary? NDT Plus; 2010 Aug;3(4):366-71

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary?
  • Objective . This study aims to highlight the challenges in the diagnosis of hyperparathyroidism (HPT) in patients with advanced chronic kidney disease (CKD).
  • Results . Evaluation confirmed the presence of a large parathyroid adenoma; HPT and hypercalcaemia resolved rapidly following resection.
  • Conclusion . This case report is remarkable for its severe hypercalcaemia requiring haemodialysis, large adenoma size, acute-on-chronic kidney injury and markedly elevated PTH concentration in association with primary HPT in CKD.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25949433.001).
  • [ISSN] 1753-0784
  • [Journal-full-title] NDT plus
  • [ISO-abbreviation] NDT Plus
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / K24 DK085446
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC4421527
  • [Keywords] NOTNLM ; PTH / parathyroid adenoma / parathyroid hormone / primary hyperparathyroidism / tertiary hyperparathyroidism
  •  go-up   go-down


91. Vargemezis V, Liakopoulos V, Kriki P, Panagoutsos S, Leontsini M, Passadakis P, Thodis E: Pivotal role of paricalcitol in the treatment of calcific uremic arteriolopathy in the presence of a parathyroid adenoma. Am J Kidney Dis; 2010 Jan;55(1):144-7
Hazardous Substances Data Bank. PARICALCITOL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pivotal role of paricalcitol in the treatment of calcific uremic arteriolopathy in the presence of a parathyroid adenoma.
  • Calcific uremic arteriolopathy, or calciphylaxis, is a serious and life-threatening complication of end-stage renal disease.
  • We report a case of a woman on maintenance hemodialysis therapy with calciphylaxis and parathyroid adenoma who refused to undergo parathyroidectomy.
  • [MeSH-major] Adenoma / complications. Arterial Occlusive Diseases / drug therapy. Arterioles. Calcinosis / drug therapy. Ergocalciferols / therapeutic use. Parathyroid Neoplasms / complications. Uremia / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
  • (PMID = 19481317.001).
  • [ISSN] 1523-6838
  • [Journal-full-title] American journal of kidney diseases : the official journal of the National Kidney Foundation
  • [ISO-abbreviation] Am. J. Kidney Dis.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bone Density Conservation Agents; 0 / Ergocalciferols; 6702D36OG5 / paricalcitol
  •  go-up   go-down


92. Mei H, Zheng L, Zhou C, Tong Q: Metanephric adenoma in a 2-year-old child: case report and immunohistochemical observations. J Pediatr Hematol Oncol; 2010 Aug;32(6):489-93
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metanephric adenoma in a 2-year-old child: case report and immunohistochemical observations.
  • SUMMARY: Renal metanephric adenoma (MA) is an extremely rare benign tumor, especially in children under the age of 12 years old.
  • Magnetic resonance scan revealed a mass of right kidney that was hypointense and hyperintense on T1- and T2-weighted images, respectively.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20539237.001).
  • [ISSN] 1536-3678
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


93. Yang XJ, Zhou M, Hes O, Shen S, Li R, Lopez J, Shah RB, Yang Y, Chuang ST, Lin F, Tretiakova MM, Kort EJ, Teh BT: Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol; 2008 Feb;32(2):177-87
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.
  • The nature of tubulocystic carcinoma, a rare renal tumor composed of tubular and cystic structures, is poorly understood.
  • It has been suggested that it may represent a low-grade collecting duct carcinoma of the kidney despite the lack of sufficient molecular and pathologic evidence.
  • The aim of this study was to examine the clinical and pathologic features of 13 cases of tubulocystic carcinoma of the kidney.
  • Furthermore, using gene expression microarray analysis, we defined the molecular signature of this tumor by comparing it with other renal tumors in our previously established molecular profile database.
  • Five of the 13 cases coexisted with papillary renal cell carcinoma (RCC) (n=3) or papillary adenoma (n=2).
  • Therefore, based on its unique pathologic features and molecular signature as well as its biologic behavior to develop metastasis either by itself or in association with papillary RCC, tubulocystic carcinoma of the kidney should be recognized as a distinct subtype of RCC and be distinguished from other malignant and benign cystic lesions of the kidney.
  • [MeSH-major] Adenocarcinoma / pathology. Carcinoma, Renal Cell / secondary. Chromosome Aberrations. Cystadenocarcinoma / pathology. Kidney Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18223319.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Amar L, Plouin PF, Steichen O: Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis; 2010;5:9
HAL archives ouvertes. Full text from .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
  • Unilateral aldosterone hypersecretion is caused by an aldosterone-producing adenoma (also known as Conn's adenoma and aldosteronoma), primary unilateral adrenal hyperplasia and rare cases of aldosterone-producing adrenocortical carcinoma.
  • Its prevalence in referred hypertensive populations is estimated to be between 6 and 13%, of which 1.5 to 5% have an aldosterone-producing adenoma or primary unilateral adrenal hyperplasia.
  • The differential diagnosis of hypokalemic hypertension with low renin includes mineralocorticoid excess, with the mineralocorticoid being cortisol or 11-deoxycorticosterone, apparent mineralocorticoid excess, pseudo-hypermineralocorticoidism in Liddle syndrome or exposure to glycyrrhizic acid.
  • Once the diagnosis is confirmed, adrenal computed tomography is performed for all patients.
  • [MeSH-major] Adrenocortical Adenoma / diagnosis. Adrenocortical Adenoma / metabolism. Aldosterone / metabolism. Hyperaldosteronism / diagnosis. Hyperaldosteronism / surgery

  • Genetic Alliance. consumer health - Primary aldosteronism.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8 [15837256.001]
  • [Cites] J Urol. 2005 Jul;174(1):40-3 [15947573.001]
  • [Cites] Radiographics. 2005 Oct;25 Suppl 1:S143-58 [16227488.001]
  • [Cites] Surgery. 2005 Dec;138(6):1009-16; discussion 1016-7 [16360385.001]
  • [Cites] J Hum Hypertens. 2006 Feb;20(2):129-36 [16292348.001]
  • [Cites] Am Surg. 2005 Oct;71(10):864-9 [16468537.001]
  • [Cites] J Hypertens. 2006 Feb;24(2):371-9 [16508586.001]
  • [Cites] JAMA. 2006 Jun 14;295(22):2638-45 [16772627.001]
  • [Cites] J Am Coll Cardiol. 2006 Dec 5;48(11):2293-300 [17161262.001]
  • [Cites] Hypertension. 2007 Apr;49(4):846-56 [17296870.001]
  • [Cites] Hypertens Res. 2007 Feb;30(2):111-7 [17460380.001]
  • [Cites] Clin Endocrinol (Oxf). 2007 May;66(5):607-18 [17492946.001]
  • [Cites] J Hypertens. 2007 Jul;25(7):1433-42 [17563566.001]
  • [Cites] ANZ J Surg. 2007 Sep;77(9):768-73 [17685956.001]
  • [Cites] J Hypertens. 2007 Sep;25(9):1751-62 [17762635.001]
  • [Cites] Ann Endocrinol (Paris). 2007 Oct;68(5):349-56 [17368420.001]
  • [Cites] Am J Hypertens. 2007 Dec;20(12):1334-7 [18047926.001]
  • [Cites] Surgery. 2007 Dec;142(6):921-9; discussion 921-9 [18063077.001]
  • [Cites] J Vasc Interv Radiol. 2008 Jan;19(1):66-71 [18192469.001]
  • [Cites] Arch Intern Med. 2008 Jan 14;168(1):80-5 [18195199.001]
  • [Cites] Ann Surg. 2008 Mar;247(3):511-8 [18376197.001]
  • [Cites] Endocr Rev. 2008 Apr;29(2):133-54 [18292466.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Apr;93(4):1366-71 [18198224.001]
  • [Cites] Hypertension. 2008 May;51(5):1366-71 [18347224.001]
  • [Cites] Lancet. 2008 Jun 7;371(9628):1921-6 [18539224.001]
  • [Cites] Clin Endocrinol (Oxf). 2008 Jul;69(1):20-8 [18284637.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Jul;93(7):2454-62 [18413427.001]
  • [Cites] Horm Metab Res. 2008 Jul;40(7):435-41 [18493881.001]
  • [Cites] J Hypertens. 2008 Sep;26(9):1816-23 [18698217.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Sep;93(9):3266-81 [18552288.001]
  • [Cites] Chirurg. 2008 Nov;79(11):1087-94; quiz 1095-6 [18941729.001]
  • [Cites] Surgery. 2008 Dec;144(6):926-33; discussion 933 [19040999.001]
  • [Cites] Clin Endocrinol (Oxf). 2009 Jan;70(1):14-7 [19128364.001]
  • [Cites] Ann Surg. 2009 Feb;249(2):318-21 [19212188.001]
  • [Cites] Hypertension. 2009 Apr;53(4):605-10 [19221213.001]
  • [Cites] J Hum Hypertens. 2009 Apr;23(4):292-4 [18754018.001]
  • [Cites] Clin Chem. 2009 May;55(5):867-77 [19264850.001]
  • [Cites] Biomed Pharmacother. 2000 Jun;54 Suppl 1:164s-168s [10915016.001]
  • [Cites] Ann Intern Med. 2009 Sep 1;151(5):329-37 [19721021.001]
  • [Cites] Hypertension. 2010 Jan;55(1):83-9 [19933925.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Feb;85(2):637-44 [10690869.001]
  • [Cites] Biomed Pharmacother. 2000 Jun;54 Suppl 1:83s-85s [10914999.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Mar;86(3):1066-71 [11238487.001]
  • [Cites] Am J Kidney Dis. 2001 Apr;37(4):699-705 [11273868.001]
  • [Cites] Ann Intern Med. 2001 Aug 21;135(4):258-61 [11511140.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Sep;86(9):4292-8 [11549664.001]
  • [Cites] Cancer Res. 2001 Sep 15;61(18):6762-7 [11559548.001]
  • [Cites] Am J Med Sci. 2001 Dec;322(6):302-7 [11780687.001]
  • [Cites] Metabolism. 2002 Mar;51(3):350-5 [11887172.001]
  • [Cites] Endocrinol Metab Clin North Am. 2002 Sep;31(3):619-32, xi [12227124.001]
  • [Cites] Am J Hypertens. 2002 Oct;15(10 Pt 1):896-902 [12372677.001]
  • [Cites] Hypertension. 2002 Dec;40(6):892-6 [12468575.001]
  • [Cites] Hypertension. 2002 Dec;40(6):897-902 [12468576.001]
  • [Cites] J Urol. 2003 Jan;169(1):32-5 [12478096.001]
  • [Cites] Nucl Med Commun. 2003 Jun;24(6):683-8 [12766605.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Jun;88(6):2489-94 [12788844.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Aug;88(8):3637-44 [12915648.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Mar;89(3):1045-50 [15001583.001]
  • [Cites] Endocr Rev. 2004 Apr;25(2):309-40 [15082524.001]
  • [Cites] Mol Cell Endocrinol. 2004 Mar 31;217(1-2):33-9 [15134798.001]
  • [Cites] Br J Surg. 2004 Oct;91(10):1259-74 [15376201.001]
  • [Cites] Arch Intern Med. 1981 Nov;141(12):1589-93 [7030245.001]
  • [Cites] Am J Cardiol. 1987 Oct 1;60(10):820-5 [3661395.001]
  • [Cites] J Hypertens Suppl. 1987 Dec;5(5):S103-6 [2832571.001]
  • [Cites] J Hum Hypertens. 1988 Oct;2(3):187-9 [3236322.001]
  • [Cites] Am J Hypertens. 1990 Jul;3(7):576-82 [2194512.001]
  • [Cites] J Clin Endocrinol Metab. 1992 Jul;75(1):323-7 [1619026.001]
  • [Cites] Surgery. 1992 Dec;112(6):987-93 [1455323.001]
  • [Cites] J Urol. 1993 Nov;150(5 Pt 1):1365-8 [8411401.001]
  • [Cites] Clin Radiol. 1994 Jul;49(7):453-5 [8088036.001]
  • [Cites] Clin Exp Pharmacol Physiol. 1994 Apr;21(4):319-22 [7923899.001]
  • [Cites] Ann Intern Med. 1994 Dec 1;121(11):877-85 [7978702.001]
  • [Cites] J Clin Invest. 1995 Nov;96(5):2236-46 [7593610.001]
  • [Cites] Radiology. 1996 Feb;198(2):309-12 [8596821.001]
  • [Cites] J Pediatr Surg. 1996 Mar;31(3):430-2 [8708918.001]
  • [Cites] Surgery. 1998 Dec;124(6):1128-33 [9854594.001]
  • [Cites] Lancet. 1999 Apr 17;353(9161):1341-7 [10218547.001]
  • [Cites] Arch Surg. 1999 Jun;134(6):628-31; discussion 631-2 [10367872.001]
  • [Cites] Ann Intern Med. 1999 Jul 20;131(2):105-8 [10419425.001]
  • [Cites] J Lab Clin Med. 1955 Jan;45(1):3-17 [13233623.001]
  • [Cites] JAMA. 1964 Oct 19;190:213-21 [14246592.001]
  • [Cites] Lancet. 2005 Jan 15-21;365(9455):217-23 [15652604.001]
  • [Cites] Surgery. 2004 Dec;136(6):1227-35 [15657580.001]
  • (PMID = 20482833.001).
  • [ISSN] 1750-1172
  • [Journal-full-title] Orphanet journal of rare diseases
  • [ISO-abbreviation] Orphanet J Rare Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone
  • [Number-of-references] 83
  • [Other-IDs] NLM/ PMC2889888
  •  go-up   go-down


95. Merante-Boschin I, Fassan M, Pelizzo MR, Ide EC, Rugge M: Neck emergency due to parathyroid adenoma bleeding: a case report. J Med Case Rep; 2009;3:7404
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neck emergency due to parathyroid adenoma bleeding: a case report.
  • INTRODUCTION: The spontaneous rupture of a parathyroid adenoma accompanied by extracapsular hemorrhage is a rare, potentially fatal, condition and is a cervicomediastinal surgical emergency.
  • CASE PRESENTATION: This report describes an atypical two-step spontaneous rupture of an asymptomatic parathyroid adenoma in a 56-year-old Caucasian woman who presented with a painful mass in the right side of her neck.
  • CONCLUSION: Based on this case report and similar cases reported in the medical literature, a diagnosis of extracapsular parathyroid hemorrhage should be considered when a non-traumatic sudden neck swelling coexists with hypercalcemia and regional ecchymosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Otolaryngol Head Neck Surg. 2006 Apr;134(4):710-2 [16564403.001]
  • [Cites] Endocr Pract. 2001 Jan-Feb;7(1):32-6 [11250766.001]
  • [Cites] J Clin Endocrinol Metab. 1953 Aug;13(8):997-1008 [13069604.001]
  • [Cites] Aust N Z J Surg. 1998 Aug;68(8):619-21 [9715147.001]
  • [Cites] Presse Med. 1997 Dec 20;26(40):1969 [9536995.001]
  • [Cites] J Laryngol Otol. 1997 Jun;111(6):585-7 [9231101.001]
  • [Cites] Ann Chir. 1994;48(9):867-9 [7702348.001]
  • [Cites] Ear Nose Throat J. 1993 Dec;72(12):794-9 [8313863.001]
  • [Cites] Dysphagia. 1993;8(1):7-10 [8436023.001]
  • [Cites] Nephron. 1985;39(1):66-7 [3969195.001]
  • [Cites] Presse Med. 1989 Oct 7;18(31):1524-5 [2530517.001]
  • [Cites] Arch Surg. 1989 Nov;124(11):1347-50 [2684095.001]
  • [Cites] Am J Med Sci. 1989 May;297(5):331-3 [2655447.001]
  • [Cites] Presse Med. 1990 Jun 23;19(25):1197 [2142291.001]
  • [Cites] Presse Med. 1990 Apr 28;19(17):817 [2140173.001]
  • [Cites] Surgery. 1981 Jun;89(6):697-700 [7245031.001]
  • [Cites] Arch Surg. 1974 May;108(5):740-1 [4829792.001]
  • [Cites] Chest. 1975 Dec;68(6):844-6 [1192872.001]
  • [Cites] Emerg Radiol. 2004 Feb;10(4):213-5 [15290495.001]
  • [Cites] Ann Chir. 2003 Oct;128(8):561-2 [14559311.001]
  • [Cites] Head Neck. 2003 Aug;25(8):695-9 [12884353.001]
  • [Cites] Surg Today. 2003;33(5):354-7 [12734730.001]
  • [Cites] Surg Today. 2002;32(9):809-11 [12203060.001]
  • [Cites] Surg Today. 2001;31(3):222-4 [11318124.001]
  • [Cites] Am J Kidney Dis. 2005 Jun;45(6):e109-14 [15957122.001]
  • (PMID = 19830200.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2726549
  •  go-up   go-down


96. Bahrami A, Schwartz MR, Ayala AG, Goldfarb RA, Brady JR, Takei H, Ro JY: Concurrent angiomyolipoma and two oncocytomas in the same kidney. Ann Diagn Pathol; 2007 Apr;11(2):132-6
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Concurrent angiomyolipoma and two oncocytomas in the same kidney.
  • We report on a rare case of synchronous angiomyolipoma (AML) and 2 oncocytomas (OCs) in the same kidney of a 73-year-old woman.
  • During the course of a follow-up for a long-standing staghorn calculus in the left kidney, a 4-cm right suprarenal mass and a small solid nodule adjacent to a cyst in the midportion of the right kidney were radiographically discovered.
  • An additional OC (0.8 cm) elsewhere in the right kidney was also identified.
  • The coexistence of AML and other renal tumors is uncommon.
  • Among reported cases, conventional renal cell carcinoma, possibly reflecting its higher incidence, has been the most common concurrent tumor with AML.
  • Although only rare cases of simultaneous AML and OC have been reported in the literature, it appears that the proportion of OC among concurrent renal tumors with AML is higher than expected based on its frequency among all surgically resected renal neoplasms.
  • [MeSH-major] Adenoma, Oxyphilic / pathology. Angiomyolipoma / pathology. Kidney Neoplasms / pathology. Neoplasms, Multiple Primary / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17349574.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins
  •  go-up   go-down


97. Mallya SM, Wu HI, Saria EA, Corrado KR, Arnold A: Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma. J Bone Miner Res; 2010 Dec;25(12):2606-12
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tissue-specific regulatory regions of the PTH gene localized by novel chromosome 11 rearrangement breakpoints in a parathyroid adenoma.
  • Parathyroid adenomas can contain clonal rearrangements of chromosome 11 that activate the cyclin D1 oncogene through juxtaposition with the PTH gene.
  • Southern blot analyses of the parathyroid adenoma revealed rearrangement in the PTH gene locus.

  • Genetic Alliance. consumer health - Chromosome 11.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 American Society for Bone and Mineral Research.
  • [Cites] Blood. 2000 Apr 15;95(8):2691-8 [10753852.001]
  • [Cites] Nucleic Acids Res. 1990 Oct 11;18(19):5677-83 [1977134.001]
  • [Cites] J Clin Invest. 2001 May;107(9):1093-102 [11342573.001]
  • [Cites] Int J Oncol. 2002 Mar;20(3):463-6 [11836555.001]
  • [Cites] Genome Res. 2002 Apr;12(4):656-64 [11932250.001]
  • [Cites] J Mol Endocrinol. 2002 Oct;29(2):193-203 [12370121.001]
  • [Cites] Nucleic Acids Res. 2003 Jan 1;31(1):51-4 [12519945.001]
  • [Cites] Oncogene. 1991 Mar;6(3):449-53 [2011400.001]
  • [Cites] Nature. 2001 Feb 15;409(6822):860-921 [11237011.001]
  • [Cites] Nature. 1991 Apr 11;350(6318):512-5 [1826542.001]
  • [Cites] J Biol Chem. 1991 Nov 15;266(32):21903-10 [1939213.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9638-42 [1682919.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8097-101 [1325645.001]
  • [Cites] Leukemia. 1993 Feb;7(2):241-5 [8426477.001]
  • [Cites] Int J Cancer. 1994 May 1;57(3):353-61 [8168995.001]
  • [Cites] J Biol Chem. 1994 Nov 11;269(45):27855-62 [7961715.001]
  • [Cites] J Clin Endocrinol Metab. 1996 May;81(5):1736-9 [8626826.001]
  • [Cites] Biochemistry. 1996 Nov 26;35(47):14679-83 [8942627.001]
  • [Cites] Blood. 1997 Jan 1;89(1):349-50 [8978314.001]
  • [Cites] Cancer Genet Cytogenet. 1997 Jul 15;96(2):95-101 [9216713.001]
  • [Cites] Kidney Int. 1999 Apr;55(4):1375-83 [10201002.001]
  • [Cites] Arch Biochem Biophys. 1999 May 1;365(1):123-30 [10222046.001]
  • [Cites] Mod Pathol. 1999 Apr;12(4):412-6 [10229506.001]
  • [Cites] BMC Bioinformatics. 2005;6:79 [15799782.001]
  • [Cites] Endocrinology. 2005 Aug;146(8):3409-16 [15890770.001]
  • [Cites] Mol Endocrinol. 2005 Oct;19(10):2603-9 [15928311.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Feb;91(2):580-3 [16263810.001]
  • [Cites] Genes Chromosomes Cancer. 2008 Aug;47(8):639-48 [18398822.001]
  • [Cites] Prostate. 2009 Apr 1;69(5):559-69 [19142959.001]
  • [Cites] J Bone Miner Res. 2009 Jul;24(7):1173-9 [19257819.001]
  • [Cites] Genome Res. 2003 Jan;13(1):73-80 [12529308.001]
  • [Cites] Endocrinology. 2003 Jul;144(7):3138-47 [12810570.001]
  • [Cites] J Bone Miner Res. 2003 Jul;18(7):1326-31 [12854844.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Mar;149(2):114-9 [15036886.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Mar;149(2):120-4 [15036887.001]
  • [Cites] Endocrinology. 2004 Jun;145(6):2713-20 [15001549.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Oct;76(10):4981-5 [388425.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Dec;78(12):7365-9 [6950381.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 Apr;80(8):2127-31 [6220408.001]
  • [Cites] Gene. 1984 Jun;28(3):319-29 [6086460.001]
  • [Cites] N Engl J Med. 1988 Mar 17;318(11):658-62 [3344017.001]
  • [Cites] J Clin Invest. 1989 Jun;83(6):2034-40 [2723071.001]
  • [ErratumIn] J Bone Miner Res. 2011 Feb;26(2):439
  • (PMID = 20641034.001).
  • [ISSN] 1523-4681
  • [Journal-full-title] Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • [ISO-abbreviation] J. Bone Miner. Res.
  • [Language] ENG
  • [Grant] United States / NIDCR NIH HHS / DE / R03 DE016337-02; United States / NIDCR NIH HHS / DE / DE016337; United States / NIDCR NIH HHS / DE / DE14773; United States / NIDCR NIH HHS / DE / DE016337-02; United States / NIDCR NIH HHS / DE / R03 DE016337; United States / Howard Hughes Medical Institute / / ; United States / NIDCR NIH HHS / DE / DE014773-05; United States / NIDCR NIH HHS / DE / K22 DE014773; United States / NIDCR NIH HHS / DE / K22 DE014773-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Parathyroid Hormone; 0 / Transcription Factors; 136601-57-5 / Cyclin D1
  • [Other-IDs] NLM/ NIHMS301996; NLM/ PMC3119366
  •  go-up   go-down


98. Lin YT, Chang CH, Chen WC: Asymptomatic congenital splenorenal shunt in a noncirrhotic patient with a left adrenal aldosterone-producing adenoma. Kaohsiung J Med Sci; 2009 Dec;25(12):669-74
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Asymptomatic congenital splenorenal shunt in a noncirrhotic patient with a left adrenal aldosterone-producing adenoma.
  • Here, we present a case of a venous shunt between the spleen and left renal vein in a 57-year-old man with no history of liver cirrhosis, portal hypertension, or hepatic encephalopathy.
  • The abnormal vessel was identified on preoperative contrast-enhanced computed tomography performed for diagnosis of a left adrenal aldosterone-producing adenoma.
  • [MeSH-major] Adenoma / metabolism. Adrenal Gland Neoplasms / metabolism. Aldosterone / biosynthesis. Kidney / blood supply. Spleen / blood supply

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19951853.001).
  • [ISSN] 1607-551X
  • [Journal-full-title] The Kaohsiung journal of medical sciences
  • [ISO-abbreviation] Kaohsiung J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone
  •  go-up   go-down


99. Trapeznikova MF, Urenkov SB, Zubrilina NM, Podoĭnitsyn AA: [Current trends in the treatment of urological patients with transplanted kidney]. Urologiia; 2009 Mar-Apr;(2):9-13
MedlinePlus Health Information. consumer health - Kidney Transplantation.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Current trends in the treatment of urological patients with transplanted kidney].
  • The examination and surgical treatment were performed in 34 kidney recipients (22 males and 12 females aged 16-65 years) with different urological diseases admitted to the urological clinic of M. F.
  • Vladimirsky Moscow Region Research Clinical Institute in 1992-2007 3 weeks to 15 years after kidney transplantation.
  • Most of the patients had urolithiasis, prostatic adenoma, some patients had renal cyst, implanted kidney tumor, tumor of the arteriosclerotic kidneys, posterior urethra stricture, posterior urethra valve.
  • Transurethral (retrograde) x-ray-endoscopic operations for removal of the transplanted kidney uroliths were not conducted as the newly created ostium in the upper part of the urinary bladder made it impossible to use a retrograde approach for elimination of the concrements.
  • Kidney recipients with prostatic adenoma (2 and 5 years after transplantation) in 3 cases were subjected to scheduled TUR because of manifest obstructive symptoms.
  • Thus, low invasive surgical interventions in kidney recipients with urological diseases have changed routive approaches to treatment of such patients consisting in open surgery which was often cancelled because of contraindications.
  • Prostatic adenoma is treated, as a rule, surgically (TUR of the prostate).
  • [MeSH-major] Kidney Transplantation. Prostatic Hyperplasia / therapy. Urologic Diseases / therapy

  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19526868.001).
  • [ISSN] 1728-2985
  • [Journal-full-title] Urologii︠a︡ (Moscow, Russia : 1999)
  • [ISO-abbreviation] Urologiia
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


100. D'Antonio A, Caleo A, Caleo O, Addesso M, Boscaino A: Hepatocellular carcinoma metastatic to the kidney mimicking renal oncocytoma. Hepatobiliary Pancreat Dis Int; 2010 Oct;9(5):550-2
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatocellular carcinoma metastatic to the kidney mimicking renal oncocytoma.
  • BACKGROUND: Renal metastases of hepatocellular carcinoma (HCC) are very rare.
  • METHODS: We describe the clinico-pathological features of a rare case of HCC metastatic to the kidney in which the renal mass was the clinical debut of disease.
  • The patient was a 54-year-old woman previously submitted to orthotopic liver transplantation, who underwent left nephrectomy for a renal mass.
  • RESULTS: Histologically, the tumor was composed mainly of epithelioid cells with homogeneous acidophilic cytoplasm resembling oncocytoma or primary renal carcinoma with oncocytic features.
  • A correct diagnosis was made on the basis of positive immunostaining for hepatocyte paraffin 1.
  • CONCLUSIONS: Metastasis to the kidney is a rare complication that should be considered whenever a renal mass is present in patients with HCC.
  • Since HCC may histologically resemble primary renal tumors such as oncocytoma, pathologists must be aware of this possibility above all in patients referred for liver transplantation and treated with immunosuppressant drugs.
  • Immunohistochemistry is particularly helpful to establish a precise diagnosis in cases of doubt.
  • [MeSH-major] Carcinoma, Hepatocellular / diagnosis. Carcinoma, Hepatocellular / pathology. Kidney Neoplasms / diagnosis. Kidney Neoplasms / secondary. Liver Neoplasms / diagnosis. Liver Neoplasms / pathology
  • [MeSH-minor] Adenoma, Oxyphilic / diagnosis. Diagnosis, Differential. Fatal Outcome. Female. Humans. Liver Transplantation / pathology. Middle Aged. Neoplasm Metastasis

  • Genetic Alliance. consumer health - Oncocytoma renal.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20943467.001).
  • [ISSN] 1499-3872
  • [Journal-full-title] Hepatobiliary & pancreatic diseases international : HBPD INT
  • [ISO-abbreviation] HBPD INT
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] Oncocytoma, renal
  •  go-up   go-down






Advertisement